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ABSTRACT 
Volatile organic compounds (VOCs) are organic chemicals typically characterized as having low 
molecular weight, low solubility in water, and high vapor pressure. Consequently, they readily evaporate 
from liquid to the gaseous phase at standard temperature and pressure. VOCs are produced by many 
microorganisms as a result of both uninduced and induced metabolic pathways. Volatile-based microbial 
inhibition in environments such as soil is well founded, with numerous antimicrobial VOCs and 
formulations having been identified. Inhibitory VOCs are of particular interest as microbial control 
agents, as low concentrations of gaseous VOCs have been observed to elicit significant antimicrobial 
effects. It is believed that this contact-independent antagonism may present unique advantages over 
traditional microbial control methods, particularly where contact-dependent treatment methods are either 
impractical or inconvenient. This method may be of particular benefit for managing infections where 
disease may become pervasive in the population, such as with white-nose syndrome (WNS) among bats. 
A list of potential antifungal compounds and formulations was compiled by referencing the 
scientific literature. Screening of compounds and formulations was conducted through toxicity analyses 
and antimicrobial susceptibility testing for the in vitro ability of VOCs and formulations to inhibit growth 
of select pathogenic fungi. A dispersal system was developed that entailed electrical circuit and software 
engineering as well as quantitative analysis to validate consistent and accurate dispersal of potential 
treatment compounds and formulations. Successful completion of these goals culminated in exposure 
trials involving live bats to determine any significant toxicological effects. Ex and in situ treatment trials 
were conducted to determine efficacy of promoting the reduction of disease severity and increasing 
survivorship of infected bat populations. The identification of volatile-based inhibitory compounds, in 
conjunction with a novel method for accurate and automated delivery, could prove a promising treatment 
and prophylactic in combatting microbial pathogenesis and contamination. 
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1 
1 INTRODUCTION 
1.1 Background 
 
Biomimicry is an approach to developing solutions to problems by emulating the 
successful survival strategies found throughout nature. Microorganisms have invested billions of 
years of combined research and development via evolution. If failure has resulted in extinction, 
then those that thrive hold not just the key to their survival, but also to our prosperity. In the 
pursuit of developing novel microbial control methods, we need look no further than the arena 
these organisms compete in for survival to discover effective tools for controlling undesired 
microbial growth. 
The fitness of an organism or species is influenced by numerous factors. Competition is 
one such interaction that often promotes the fitness of one species, to the detriment of another. 
The competitive exclusion principle is the theory that different species in competition for the 
same resources cannot maintain coexistence if they share the same ecological niche (Gause, 
1934). Although additional factors have been identified that continue to shape our understanding 
of coexistence (Rastetter and Gren, 2002), the ability of a species to thrive largely hinges on the 
competitive advantages its members have over others. Among the many adaptive mechanisms 
microorganisms have evolved to compete is the production and dissemination of antimicrobial 
compounds. 
 
1.2 Microbial Antagonism 
 
Antibiotics are one class of antimicrobial compounds produced by microorganisms, 
which may be further classified by mechanism of action, molecular structure, and spectrum of 
activity, among other characteristics. While some of the first antibiotics to be discovered were 
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the products of eukaryotic fungi (Fleming, 1929), it has been revealed a great number are also 
produced by prokaryotes, such as Streptomyces spp. (Watve et al., 2001). 
Another novel class of antimicrobials was discovered following observations of fungal 
spore germination being inhibited when exposed to certain soil substrates, termed fungistatic 
soils (Dobbs and Hinson, 1953). The inhibitory properties of these suppressive soils were later 
found to be a result of exposure to microbially-produced volatile organic compounds (VOCs) 
(Balis and Kouyeas, 1968). VOCs are chemical compounds typically characterized by their low 
molecular weight, low boiling point, low solubility in water, and high vapor pressure. These 
characteristics often facilitate evaporation to the gaseous phase at standard temperature and 
pressure (STP). The dissemination of these compounds into the surrounding airspace has enabled 
microorganisms to interact and elicit antagonistic effects from a greater distance than could be 
achieved by direct contact. The ability of a microorganism to utilize antifungal VOCs to 
negatively impact another microorganism without requiring direct contact has been termed 
contact-independent antagonism. 
The volatile-based fungistatic properties of suppressive soils has been widely observed 
across terrestrial environments (Zou et al., 2011). The inhibitory activities of VOCs are of 
particular interest due to the ability of these compounds to inhibit microbial growth in dense and 
diverse ecosystems, from a gaseous, contact-independent exposure (Balis and Kouyeas, 1968; 
Voisard et al., 1989; Kerr et al., 1999; Ezra et al., 2003; Chuankun et al., 2004; Garbeva et al., 
2011). Recent research has begun investigating microbially-produced VOCs for their potential 
agricultural benefits, by preventing infection through controlling phytopathogenic fungi as well 
as stimulating crop growth (Weisskopf, 2013). Additionally, investigations have demonstrated 
the ability of a ubiquitous soil-dwelling bacterium, Rhodococcus Rhodochrous strain DAP 
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96253, to inhibit the growth of several fungal pathogens and spoilage organisms, including 
Pseudogymnoascus destructans, when induced for antifungal activity and placed in a shared 
airspace with the target organism (Pierce et al., 2011; Cornelison et al., 2014). The low inhibitory 
concentrations observed with select VOCs suggest a potential to utilize these compounds in 
novel ways to combat undesired microbial growth and infection. 
 
1.3 White-Nose Syndrome 
 
Emerging fungal diseases (EFDs) have become a growing concern for wildlife and food 
security, with several plant and animal pathogens posing direct threats to biodiversity and food 
production in the US and around the world (Fisher et al., 2012). One particular fungus has 
recently been exposed to naive species of bats in North America, and left unchecked, threatens 
certain bat species with population decline and extinction. 
Pseudogymnoascus destructans, a psychrophilic ascomycete, has been identified as the 
etiological agent responsible for a deadly EFD among North American bats, known as white-
nose syndrome (WNS) (Blehert et al., 2009; Lorch et al., 2011). WNS is typified by an invasion 
of the host tissue by P. destructans during torpor, which typically takes place through the winter 
season. During this period, the host’s body temperature and metabolic activity, including 
immune function, is greatly reduced. When bats enter torpor, their body temperature falls within 
the growth range of P. destructans (1°C to 15°C), and coupled with an inability of the immune 
system to effectively combat the infection, clinical WNS can quickly develop. The resulting 
tissue damage from fungal invasion is known to cause the disruption of thermoregulation, water 
regulation, and electrolyte balance, as well as increase the rate of torpor arousal, leading to 
premature expenditure of fat stores (Cryan et al., 2010; Verant et al., 2014). These insults have 
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led to severe population declines for several species, with up to 99% mortality in just a few years 
following the pathogen’s introduction to some hibernacula (Frick et al., 2010). 
Since its identification near Albany, New York in 2006, WNS has spread to 31 US states 
and 5 Canadian provinces (White-Nose Syndrome Map, 2017; Figure 1.1). A 2011 population 
study estimated at least 5.7 to 6.7 million bats have died from this disease (Froschauer et al., 
2012). Although ecological impacts are still being thoroughly assessed, initial analyses have 
suggested US agricultural impacts from the loss of bats may range from $3.7 to $53 billion per 
year, which is predominantly impacted by the loss of the insect-control bats provide (Boyles et 
al., 2011). However, this estimate only accounts for the cost of pesticides used to compensate for 
the amount of insects consumed by bats. There may very well be other negative effects that 
emerge from the loss of bats, such as potential downstream effects from increased pesticide use, 
an increase in insect-borne diseases, or disruptions to ecological systems and predator-prey 
dynamics. 
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Figure 1.1 US and Canadian counties/districts positive for the presence of WNS, since 2006 
The map depicts the first time WNS was reported to be suspect or confirmed in a county or district. Each 
time period spans a winter bat hibernation period. Last updated April 17, 2017. 
 
The rapid spread and high mortality associated with WNS has made development of 
methods for treating and preventing P. destructans infections an important objective for wildlife 
management agencies. Accordingly, the development of methods for biological and chemical 
treatment has become a significant priority for State and Federal agencies, as outlined in the 
2011 National WNS Management Plan established by the United States Fish and Wildlife 
Service (Ballman et al., 2011). 
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Analyses of population declines have suggested that regional extinction of the hardest hit 
species, the little brown bat (Myotis lucifugus), could occur as soon as 2022, 16 years from the 
pathogen’s initial emergence in the US (Frick et al., 2010). In silico modeling has indicated a 
critical decision interval for evolutionary rescue (DIER) favors early treatment (within 11 years 
of the initial WNS emergence), and deployment of successful treatment during this time period 
may yield the greatest potential benefit to promote population stability for the little brown bat 
(Maslo and Fefferman, 2015). Furthermore, Maslo et al. suggest that a moderate 13% reduction 
in mortality could lead to stability of little brown bat populations (unpublished, 2014 WNS 
Workshop presentation). This population stability may provide the greatest benefit by 
encouraging an increased birth rate that promotes a naturally evolved resistance to develop in the 
offspring. 
 
1.4 Antifungal Volatile Organic Compounds 
 
When a gaseous VOC enters an airspace, it has a propensity to permeate and envelop the 
objects in the vicinity. Pathogenic spores and mycelia exposed to the airspace, either on a host or 
in the environment, are at risk of being affected by potential fungistatic or fungicidal activities of 
the VOC. This contact-independent antagonism has the potential to be utilized to reduce growth, 
pathogenicity, viability, or the environmental load of the target microorganism. Several 
microbially-produced antifungal VOCs have been identified from the scientific literature for 
their potential to be used for microbial control and disease management (Appendix A). Initial 
testing demonstrated the ability of single VOCs to inhibit fungal growth and conidia viability as 
well as several VOC formulations to elicit significant inhibitory synergism, when tested in the 
gaseous phase. 
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Several antimicrobial susceptibility assays with synthetic formulations were conducted 
with previously discovered formulations in order to discover novel antimicrobial effects. These 
formulations were developed from analyses of the gaseous headspace constituents of cultures of 
microorganisms that have demonstrated microbial antagonism. Muscodor crispans strain B-23 is 
a novel endophytic fungus isolated from Bolivian wild pineapple (Ananas ananassoides). The 
fungus has demonstrated an ability to inhibit several plant and human pathogens by contact-
independent antagonism (Mitchell et al., 2008; Mitchell et al., 2010). A synthetic formulation of 
the gaseous compounds produced by Muscodor crispans strain B-23 has been produced 
synthetically, which only includes compounds listed by the food and drug administration (FDA) 
as generally regarded as safe (GRAS), and has been patented (Strobel et al., 2012; Table 1.1) and 
marketed under the commercial name Flavorzon 185B (Jeneil Biotech, Inc., Saukville, WI, 
USA). This synthetic formulation, further referred to as B-23, has been demonstrated to be safe 
and of low toxicity to mammals, and has been incorporated into several commercial products, for 
use with multiple mammal species, agriculture, and food storage. Several qualities of the 
synthetic B-23 formulation make it appealing to use as a control agent, including its ability to 
inhibit growth of P. destructans, preliminary studies with bats demonstrating a non-aversion to 
B-23-soaked sachets (Last and Morris, unpublished 2014 WNS Workshop presentation), and the 
compounds appearing on the FDA list of GRAS compounds. 
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Table 1.1 The chemical composition of the B-23 formulation 
Compound 
Molecular Weight 
(g/mol) 
Percentage of 
Formulation 
Acetaldehyde 44.03 0.34% 
2-Butanone 72.06 0.69% 
Propanoic acid, 2-methyl-, methyl ester 102.07 7.47% 
Acetic acid, 2-methylpropyl ester 116.08 0.56% 
Propanoic acid, 2-methyl-, 2-methylpropyl ester 144.12 0.27% 
1-Propanol, 2-methyl- 74.07 0.44% 
2-Butenal, 2-methyl-, (E)- 84.06 0.37% 
1-Butanol, 3-methyl-, acetate 130.1 1.17% 
Propanoic acid, 2-methyl-, 2-methylbutyl ester 158.13 1.17% 
1-Butanol, 3-methyl- 88.09 1.32% 
Propanoic acid, 2-methyl- 88.05 85.89% 
Acetic acid, 2-phenylethyl ester 164.08 0.32% 
The names, molecular weights, and percentages of the most abundant constituents produced by Muscodor 
crispans strain B-23, detected using GCMS (Mitchell et al., 2010). Non-GRAS compounds have been 
excluded from the formulation. 
 
 
 
1.5 Synergistic Inhibitory Activity 
 
Synergistic inhibition is said to have occurred when the inhibitory effects observed from 
a formulation of VOCs is greater than the additive inhibitions of the same VOCs exposed singly, 
when each exposure is at the same concentration. By enhancing the antagonism of a formulation 
through synergism, the benefits have the potential to be two-fold: in addition to the formulation 
producing a greater degree of inhibition at the same concentration, there may also be reduced 
toxicity to the host by any single VOC because the concentration of each is reduced in the 
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formulation. However, it may also be possible that an increased toxicity toward the pathogen will 
also increase toxicity toward the host. 
 The presence, absence, and ratio of constituents of a formulation may also be 
manipulated to elicit target-specific effects, potentially enhancing antagonistic effects toward 
germination, mycelial growth, virulence, and sporulation, and potentially improving the host’s 
response to the pathogen. This suggests there may be an optimum period for utilizing certain 
treatment formulations based on seasonality, disease progression, and host metabolic activity, 
among other factors, in order to elicit optimum effects. 
 
1.6 Mechanisms of Inhibition 
 
Although the determination of specific mechanisms related to pathogen inhibition or host 
survivorship is beyond the scope of this investigation, it is nonetheless an important aspect to 
consider. Inhibitory mechanisms will often exploit a particular characteristic shared by a clade of 
organisms. As such, it should be recognized that a consequence of both the host and pathogen 
being members of the eukaryotic domain, many physiological characteristics are shared, and 
therefore the potential exists for collateral impacts to the host when targeting the pathogen. 
In the 16th century, Paracelsus, heralded as the father of toxicology, expressed in his 
Dritte Defensio (1538) that “all things are poison and nothing is without poison; only the dose 
makes a thing not a poison.” Indeed, modern toxicology recognizes that virtually all substances 
display dose-dependent effects. However, there are numerous compounds known to stimulate a 
positive response, either because of a genuine promotion of health or because of exposure to a 
low concentration of a toxin. This phenomenon of a generally favorable response due to 
exposure to a low concentration of a toxin or stressor is known in toxicology as hormesis, and is 
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often the opposite response than what is observed with higher doses (Southam and Ehrlich, 
1943). Although not well-understood, there have been numerous observations of the hormesis 
phenomenon, suggesting the potential to change how toxicology is understood in relation to risk 
assessment, study design, and dose-response modeling, among others (Calabrese and Baldwin, 
2003). 
The body of literature comprising known microbially-produced volatile organic 
compounds is numerous and contains a large number of chemical analogues that may also be 
potentially effective at eliciting microbial inhibition. The analyses required for determining 
inhibitory mechanisms often require in-depth metabolic and genomic study. Therefore, 
mechanisms by which many of these volatiles elicit their inhibition is not thoroughly understood. 
Prior to the initial investigation to discover the potential of several VOCs to inhibit P. 
destructans (Cornelison et al., 2014), these compounds have been observed in other studies to 
elicit inhibition of germ-tube growth (nonanal), inhibition of mycelial growth (2-ethyl-1-hexanol, 
benzaldehyde, benzothiazole, and nonanal), inhibition of pigment production (benzothiazole), 
and inhibition of spore germination (2-ethyl-1-hexanol, benzothiazole, nonanal) (Weisskopf, 
2013). Inhibition of pigment production may be of particular interest, as pigments are known 
virulence factors of several pathogenic fungi, for their ability to inactivate reactive oxygen 
species produced by the host-defense response (Taborda et al., 2008). 
In lieu of direct analysis, possible inhibitory mechanisms may be inferred from the study 
of the analogues of particular compounds. For instance, benzaldehyde derivatives are known to 
cause cytoplasmic coagulation or lysis through the disruption of the cellular membrane (Alamri 
et al., 2012). Certain azoles have been observed targeting heme-contaning proteins, interfering 
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with the production of sterols and leading to the disruption of the plasma membrane, while others 
inhibited membrane-bound enzymes or lipid biosynthesis (Ghannoum et al., 1999). 
 
1.7 Collateral Impacts 
 
 Disturbance to an environmental system, such as with the application of disease 
treatments and prophylactics, have the potential to cause non-target collateral impacts. This may 
result from the construction of infrastructure, environmental release of VOCs, the propagation of 
a transitory agent such as a microorganism, among other actions. Collateral impact assessments 
are commonly performed in the course of developing treatments for animals and their habitats to 
ensure environmentally-safe application and minimal harm to the natural environment. Since the 
focus of this work is to isolate the antimicrobial effects and separate them from the biological 
agent, thereby excluding the use of living cells, collateral impacts from the use of VOCs will be 
the primary concern with these treatments. Therefore, environmental monitoring of substrates for 
contamination as well as assessments of non-target organism effects will be conducted. 
 
1.8 Dispersal Development 
 
The existence of antimicrobial VOCs has been known for quite some time. However, 
development of their use with target-specific, contact-independent antagonism of microbial 
growth, coupled with a cost-effective, scientifically validated distribution system, has been 
lacking. A distribution system provides the ability to autonomously attain and maintain a precise 
target concentration. Potential benefits include fewer collateral impacts and greater treatment 
efficacy by accurately maintaining the target concentration, as well as lowering the risk of 
developing negative health effects associated with VOC exposure to researchers and clinicians, 
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by automating distribution. Understanding how microorganisms deploy antagonistic VOCs may 
help guide future developments in this area. 
Microorganisms have evolved over millions of years in direct competition and have 
developed complex mechanisms for effectively producing and disseminating antimicrobial 
compounds. There are several advantages to abstracting the process of disseminating these 
compounds from the biological agent (the cell). These include eliminating the time and cost of 
culturing large quantities of an organism or biological catalyst, eliminating the variability of any 
potential microbial induction processes, and eliminating the possibility of releasing a self-
propagating microorganism into the environment. Other benefits include the ability to modify 
VOC formulations and compound ratios to enhance effects, the ability to regulate the exact 
concentration being dispersed, and the ability to regulate the quality of the VOC or formulation 
constituents. 
Evaporation is often heavily influenced by surface area, with evaporation time decreasing 
as surface area increases. Therefore, by reducing the size of aerosol droplets, the surface-area-to-
volume (SA-V) ratio increases, thereby increasing the total surface area of the liquid volume. For 
a defined volume of liquid comprised of an aerosol of 3-dimensional spheres, if the radii of the 
aerosol droplets decrease by half, the number of droplets will increase 800% and the total surface 
area will increase 100%. By reducing the droplet sizes to increase the SA-V ratio, the total 
surface area of the liquid increases, decreasing the evaporation time. Several commercial 
aerosolizers currently exist on the market that produce a microscopic liquid aerosol with a high 
SA-V ratio. The properties that facilitate evaporation may be utilized by these aerosolizers to 
efficiently produce a gaseous concentration in an air space, and may be manipulated to facilitate 
accurate dispersal for volatile compounds. 
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1.9 White-Nose Syndrome Treatment 
 
Developing effective methodologies for treating bats is not without its challenges. From a 
logistical standpoint, several issues must be considered in order to develop a safe and efficacious 
treatment. During hibernation, when symptoms of WNS develop, many species congregate 
together, forming a “fused” colony of numerous individuals. In addition to promoting the spread 
of disease, these colonies may also roost in areas that make physical access to individuals 
difficult or impossible. Furthermore, handling of bats for individualized treatment is often costly 
and laborious. Handling also has the potential to cause undue stress and disturbance that may 
injure the animal or interrupt torpor, causing premature arousal and expenditure of adipose tissue 
that is vital for surviving winter hibernation. 
It is believed that antimicrobial VOCs may be utilized with a dispersal system to limit 
growth and reduce the pathogenicity of P. destructans, serving as a potential treatment and 
prophylactic for bats afflicted with WNS or at risk for developing WNS from P. destructans 
infection. Gaseous exposure to antifungal VOCs enables the possibility of eliciting contact-
independent antagonism and may overcome many of the aforementioned challenges associated 
with treating bats by providing a cost-effective means to treat bats in situ, both at the colony-
level and with minimal disturbance. 
 
1.10 Hypotheses 
 
Several theories for developing effective disease management strategies were developed 
and tested during the course of this investigation. Although not all results were conclusive, the 
following hypotheses and resulting investigations laid a solid foundation for future studies to 
continue developing effective tools for microbial control and mitigating pathogenicity. 
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It has been hypothesized that VOCs and formulations identified from the scientific 
literature to demonstrate antimicrobial effects may be utilized to inhibit the growth and 
pathogenicity of select fungal pathogens. These VOCs may be acquired as pure, synthetically-
produced compounds from a chemical supplier and may be selected and screened for an in vitro 
ability to inhibit germination, mycelial growth, sporulation, or virulence of pathogenic fungi. 
Additionally, certain VOCs, when combined in a formulation, have the potential to yield 
synergistic inhibition. As a result, a synergistic formulation would contain a lower concentration 
of each individual VOC, suggesting potential benefits of reducing toxicity of each VOC as well 
as increasing efficacy. If effective at inhibiting select fungi, these VOCs have the potential to be 
utilized to control microbial growth, reduce symptoms of disease in an afflicted host, and reduce 
environmental load. 
It has been hypothesized that a VOC distribution system can be developed from 
inexpensive, off-the-shelf components, and can consistently and reliably distribute liquid VOCs 
and their formulations to produce an accurate gaseous concentration in an airspace of a known 
volume. A distribution system coupled with target-specific antimicrobial VOCs has the potential 
to reduce or abolish fungal growth or pathogenicity after contact-independent application. This 
entails the system may be used to disseminate antifungal VOCs or VOC formulations to elicit 
bio-static or -cidal activities against organisms exposed to the airspace. It is believed that this 
contact-independent application may be used alone or synergistically with current microbial 
control practices to enhance effectiveness and may present unique advantages over traditional 
microbial control methods where contact-dependent treatment methods are either ineffective or 
impractical. 
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It has been hypothesized that, if utilized for disease management, this distribution system 
may be able to limit pathogenic fungal growth on or in a host organism, slow or prevent the 
progression of disease, reduce the symptoms of infection, or promote increased fitness and 
survivorship of affected populations. This entails that the VOCs or formulations developed from 
in vitro studies be efficacious with ex and in situ inhibition of spore germination and mycelial 
growth, or promoting health among individuals of the host population. As chemical treatments 
often only elicit temporary effects, it has been hypothesized these methods will reduce or abolish 
disease symptoms instead of conferring life-long resistance. Therefore, the proposed studies will 
be carried out with intent to promote an increase of survivorship among individuals afflicted by 
WNS, and thus promoting a naturally-evolved resistance with their progeny. 
 
2 DISPERSAL SYSTEM RESEARCH AND DEVELOPMENT 
Development of a dispersal system was carried out to enable accurate and consistent 
dispersal of VOCs to attain a target gaseous concentration in a known airspace. Electrical circuits 
and software source code were engineered and utilized to enable automated control of a dispersal 
device, using known thermodynamic principles, such as the ideal gas law, to effectively 
modulate dispersal. Design focused heavily on dispersal consistency, accuracy, autonomy, and 
extending battery life. 
 
2.1 Hardware and Manufacturing 
 
The main components of the dispersal system include an enclosure, a controlling circuit, 
a power supply, and a dispersal device. The controller was designed to accept any unregulated 
12-volt direct current (DC) power source, permitting the use of a DC battery or an adapter that 
 16 
 
converts a standard 120- or 240-volt alternating current (AC) power source to 12 DC volts. The 
controller circuit board is housed in a custom 3D-printed case to protect against short-circuits 
and provide adequate airflow surrounding the circuit board to reduce the risk of component 
failure or fire from heat build-up. All circuitry is further encased in a weatherproof enclosure to 
protect against shock and to ensure the controller and battery are not exposed to conditions that 
may jeopardize the ability of the system to operate, such as a high humidity or corrosive 
environment. 
The controller has the capability to utilize a number of different dispersal devices. In one 
iteration of the system, a Trek S pneumatic nebulizer (Pari Respiratory Equipment, Inc., 
Virginia, USA) was utilized. The pneumatic pump was powered from the controller’s power 
source and a pressure sensor was incorporated for feedback to detect low power situations and to 
permit modulating the output to maintain accurate dispersal. A diagram was developed to 
visualize the interaction of the various hardware of this system (Figure 2.1). 
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Figure 2.1 Hardware diagram of the dispersal controller and a jet nebulizer 
 
In another iteration of the system, a Dyna-Jet L-30 rotary atomizer (Curtis Dyna-Fog, 
Indiana, USA) was powered by a solid state relay from its own high-current battery power 
supply (Figure 2.2). Both systems utilized the same controller but relied on different dispersal 
devices, each uniquely-suited to treating different volume airspaces. The jet nebulizer has been 
ideal for developing methodologies and performing experiments in a laboratory setting, however 
the increased airspace when moving to field application has necessitated the use of a dispersal 
device that was better-suited to large-volume dispersal, such as the L-30. 
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Figure 2.2 Hardware diagram of the dispersal controller and the L30 rotary atomizer 
 
2.2 Circuit Development 
 
Theorized controller circuits were developed from the hardware diagrams, utilizing 
several electrical components (Table 2.1). The controller circuit was developed on a prototyping 
breadboard to assess the operability of theorized circuit and program designs. A MAX16910 
ultra-low quiescent current voltage regulator (Maxim Integrated, California, USA) was selected 
to convert and regulate a steady 3.3-volt DC power supply to the controller components and 
peripherals, from an unregulated 12-volt DC power input. The ATMega328p AVR 
microcontroller unit (MCU; Atmel, California, USA) was selected as the main integrated circuit, 
which combines a processor core, memory, and programmable input/output peripherals onto one 
chip. It features a low operating and standby power usage, memory for program and variable 
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storage, and several analog-to-digital converters for sensor integration. A solid state relay (SSR) 
or n-channel metal–oxide–semiconductor field-effect transistor (MOSFET) was selected to allow 
the MCU to modulate the high-power output to the distribution device. The DS1337 real time 
clock (RTC; Maxim Integrated, California, USA) chip is a precision low-power clock/calendar 
with alarm functions and was selected to perform all critical time-keeping operations. An SD 
card socket breakout board (Sparkfun Electronics, Colorado, USA) was selected to enable 
reading of configuration settings as well as data logging. 
Circuit prototypes were tested under various conditions likely to be experienced under 
normal operation in order to develop a robust circuit schematic (Figure 2.3). Design of the 
printed circuit board (PCB) was developed with CadSoft’s EAGLE PCB design software before 
being printed (OSH Park, Oregon, USA) and hand-assembled (Figure 2.4). 
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Table 2.1 Bill of materials used to construct one dispersal controller (version 1.4) 
Part Number (DigiKey) Quantity Description 
DS1337+-ND 1 DS1337 Real Time Clock IC 
728-1000-ND 1 32kHz Crystal 
887-2015-ND 1 16MHz Crystal 
CP3-1003-ND 1 Barrel Power Jack (male, 1.35mm ID, 3.5mm OD) 
CP3-1000-ND 1 Barrel Power Jack (male, 2.1mm ID, 5.5mm OD) 
CP-035D-ND 1 Barrel Power Jack (female, 1.35mm ID, 3.5mm OD) 
CP-002A-ND 1 Barrel Power Jack (female, 2.1mm ID, 5.5mm OD) 
BC2301-ND 1 Thermistor 10k ohm (500mW, 5%, 40C-125C) 
RNV14FAL330KCT-ND 1 Resistor 330k ohm (1/4W, 1%) 
S16KCACT-ND 1 Resistor 16k ohm (1/4W, 1%) 
A105947CT-ND 7 Resistor 10k ohm (0.6W, 1%) 
5.62KXBK-ND 1 Resistor 5.6k ohm (1/4W, 1%) 
CF14JT150RCT-ND 2 Resistor 150 ohm (1/4W, 5%) 
CF14JT100RCT-ND 1 Resistor 100 ohm (1/4W, 5%) 
516-1779-1-ND 1 LED (30mA) 
S1011EC-40-ND 1 Unshrouded Header (1x40, breakable) 
S7006-ND 2 Header - 1x8 Female 
490-7508-1-ND 1 Capacitor 4.7 µF 
399-4266-ND 1 Capacitor 0.1 µF 
490-7322-1-ND 2 Capacitor 1.0 nF 50V 5% 
1N5817-TPCT-ND 2 Diode, Schottky (20V, 1A) 
1N4001-TPMSCT-ND 1 Diode, Schottky (50V, 1A) 
A100210-ND 1 DIP Socket (2x14, 28-Pin, 0.3") 
3M5473-ND 1 DIP Socket (2x4, 8-Pin, 0.3") 
NDP6020P-ND 1 P-MOSFET (20V, 24A, Vgs(th)=1V@250uA) 
497-12703-5-ND 2 N-MOSFET (25V, 80A, Vgs(th)=1V@250uA) 
ATMEGA328P-PU-ND 1 ATMEGA328P-PU (1.8-5.5v, 20Mhz, 32KB) 
 1 Toggle switch 
 1 Toggle Switch Waterproof Cover 
MAX16910CASA9/V+-ND 1 Voltage Regulator 
522-1035-ND 1 12 volt rechargeable VRLA Battery 
MPX4250AP-ND 1 0-36 PSI analog sensor 
 1 SD-card breakout board 
The bill of materials, including DigiKey part number, quantity, and description of each part, to 
construct one controller circuit. The cost to manufacture the circuit board is not included. 
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Figure 2.3 Circuit schematic of the dispersal controller 
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Figure 2.4 Circuit board layout of the dispersal controller 
A double-sided printed circuit board (PCB) with red traces (top) and blue traces (bottom) denoting circuit 
connections. The PCB dimensions are approximately 75 mm by 47 mm. 
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2.3 Software Development 
 
Software development was performed with an emphasis on customizability, to enable 
creating a wide variety of custom treatment regimens. The durations the aerosolizer is powered 
and depowered may be defined by the user or automatically calculated based on user input of 
environmental conditions, treatment compound characteristics, and desired gaseous 
concentration in the airspace. Figure 2.5 demonstrates the logical flow of software operation and 
Figure 2.6 demonstrates the variability of several custom treatment regimens that may be 
employed to attain a desired effect. 
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Figure 2.5 Flowchart of the version 1.4.4 software of the dispersal controller 
 
 25 
 
 
 
Figure 2.6 Example program diagram of version 1.4.4 of the dispersal controller 
 
2.4 Power Efficiency 
 
Due to the remote and widely disseminated locations of many bat hibernacula, the ability 
of the dispersal system to run autonomously and on battery power are fundamental requirements 
for field deployment for the management of WNS. Battery operation greatly expands the range 
of the dispersal system outside of the built environment and facilitates in situ management of 
WNS. However, as a battery drains, both voltage and current diminish, potentially causing 
negative effects on the circuitry and/or the output of the dispersal device, which both rely on 
constant power to operate consistently. These effects can be mitigated or abolished if feedback 
systems are developed that allow real-time correction during diminishing power situations. By 
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analyzing battery drain characteristics and system energy usage or output, consistent operation 
during battery-powered use can be achieved as well as permitting a more efficient battery 
selection.  
Evaluation of the dispersal system operational characteristics was performed under 
various battery drain scenarios. These results were used to test feedback systems that sought to 
mitigate the negative effects of battery drain. Modulation of power from a benchtop regulated 
power supply (Extech, New Hampshire, USA) was used to simulate battery drain and evaluate 
system performance during battery drain scenarios. Feedback monitoring was performed with a 
MPX4250AP pressure sensor (Freescale Semiconductor, Texas, USA), with output monitored 
with an AutoSystem XL gas chromatograph (GC; PerkinElmer, Massachusetts, USA) and a 
quantitative gas analysis mass spectrometer (QGA-MS; Hiden, United Kingdom), in order to 
determine aberrant jet nebulizer output during battery drain. The results of these tests allowed 
software functions to be produced that modulated output of the jet nebulizer to rectify issues due 
to battery drain. 
 
2.5 Air Chamber Development 
 
A polypropylene glove box (Cleatech, California, USA) was used to conduct airspace 
studies involving the jet nebulizer and conduct inhibition assays. The glove box was sealed from 
the outside environment to ensure there was no airflow in or out of the box. The inner 
dimensions were measured and the total internal volume was calculated to be 2.923 x 10−1 m3. 
Bulkhead electrical ports were outfitted to transmit power to an internal circulatory fan and a 
Peltier thermoelectric device. The thermoelectric device was used to heat a watch glass 
containing aliquots of VOCs and formulations to evaporation temperatures. 
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2.6 Headspace Sampling 
 
Direct headspace sampling and analysis by GCMS was conducted for quantifying 
gaseous concentrations of compounds. Both syringe and solid-phase micro-extraction (SPME) 
fiber sampling techniques were explored for accuracy, reproducibility, and ease of use. Samples 
were extracted with either a gas-tight syringe or SPME fiber, through a bulkhead fitting with a 
septum, then injected or thermally desorbed in a heated injector port of an Agilent 7890A gas 
chromatograph connected to an Agilent 5977A mass spectrometer (GCMS, Agilent, California, 
USA). 
Several SPME fiber materials were evaluated for both the affinity and degree of 
adsorption of target compounds. Three fiber materials were selected that are commonly used to 
detect low molecular weight or volatile compounds- polydimethylsiloxane (PDMS), 
polydimethylsiloxane/carboxen (PDMS-CAR), and polydimethylsiloxane/divinylbenzene 
(PDMS-DVB). Each fiber material was exposed to a known concentration of each analyte, then 
analyzed with the GCMS. 
Programming was performed in the Arduino programming language with a combination 
of original source code and open-source libraries (Appendix D). Source code was compiled with 
the Arduino Integrated Development Environment (IDE; version 1.0.6) to produce a hex file 
containing machine code. The machine code was uploaded to the MCU with either the Arduino 
IDE or AVRDude software, using the Pocket AVR hardware programmer (Sparkfun Electronics, 
Colorado, USA). 
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3 EXPERIMENTS 
3.1 Spore Harvesting and Culture Maintenance 
 
 P. destructans isolates were obtained from Kevin Keel and his WNS diagnostic work at 
the University of Georgia’s Southeastern Cooperative Wildlife Disease Study. Conidia were 
stored at −20°C in a phosphate-buffered saline solution (PBS, Appendix B) for short-term 
storage. To prepare conidia for long-term storage, glycerol was added to the conidia-PBS 
solution to produce a solution comprised of 30% glycerol and 70% PBS. This solution was 
aliquoted into cryogenic vials (Nalgene, New York, USA) and stored at −80°C until use. 
Mycelial growth of P. destructans was propagated on Sabouraud Dextrose Agar (SDA, BD, New 
Jersey, USA) at 15°C. 
 To produce confluent lawns of P. destructans, 100 µl aliquots of conidia solution (106 
conidia ml−1) were evenly spread on the surface of SDA in 90 mm Petri dishes. Each dish was 
sealed with a paraffin film (Parafilm M, Bemis, Wisconsin, USA) and incubated at 15°C for 
approximately 3 or 6 weeks to produce confluent lawns for inhibition assays or conidia 
harvesting, respectively. 
To harvest conidia, a 10 ml aliquot of conidia harvesting solution (Appendix C) was 
dispensed onto the mycelial lawn in each Petri dish. The mycelia surface was agitated with a 
sterile loop to dislodge conidia into the harvesting solution. A serological pipette was used to 
transfer the conidia harvesting solution from the Petri dish to a conical Falcon tube (BD, New 
Jersey, USA). The solution was centrifuged at 3,000 revolutions per minute (RPM) for 10 
minutes, then the supernatant was removed and the pellet resuspended in 10 ml PBS by 
vortexing. Centrifugation and resuspension was repeated 3 times or until the supernatant became 
clear (whichever occurred first). The pellet was resuspended in 10 ml PBS by vortexing, then 
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filtered through a sterile glass wool-packed funnel to remove residual mycelial fragments. The 
glass wool was rinsed with an additional 5 ml PBS to recover remaining conidia. Spore solutions 
were either placed in short-term storage at −20°C or prepared for long-term storage at −80°C. 
 
3.2 Antimicrobial Susceptibility 
 
3.2.1 Quantification of Filamentous Fungi Growth 
 
Filamentous fungi grow by hyphae elongation instead of distinct cellular division that is 
typical of bacteria and yeast. Therefore, quantification of filamentous fungi inhibition requires 
alternative methods than the classic disc diffusion assay utilized to quantify bacteria or yeast 
inhibition, which relies on the ability of the organism to produce a zone of inhibition. Comparing 
the radial growth area of mycelia over a flat agar surface to unexposed control growth has been 
the accepted method for assessing mycelial inhibition. 
However, a ruler commonly used to measure the area of mycelial growth of filamentous 
fungi presents its own challenges. Mycelial core plugs will often grow asymmetrically, either 
naturally or as a response to exposure to control agents (Figure 3.1). To attain a greater accuracy 
in measuring mycelial growth, a technique was developed that utilized digital photography and 
computer analysis. 
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 Growth morphologies of Pseudogymnoascus destructans following a 14-day exposure to a control agent 
(a) and unexposed controls (b). 
 
The GIMP (GNU Image Manipulation Program) is open-source, freely distributed 
software for image editing. This software allows for the direct measurement between two points 
or the area selection of a digital photograph. The quantity of pixels measured, which are the 
smallest units of a digital photograph, can be converted to meters after measuring the length, in 
pixels, between demarcations of a ruler in a photograph and deriving a conversion ratio between 
pixels and meters. 
A Nikon D3100 digital single lens reflex (DSLR) camera with an 18 - 55 mm lens and a 
tripod was used to capture images. The camera was attached to the tripod and aimed down to a 
horizontal surface in order to provide a consistent distance from the lens to the object being 
photographed, ensuring the same pixel-to-meter ratio was retained for all acquired images of a 
set. If the height changed, a new calibration image of the ruler would be required to derive the 
 
a 
b 
Figure 3.1 Radial growth of Pseudogymnoascus destructans under various growth conditions 
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new pixel-to-meter ratio. Subsequent images of mycelial plugs had their corresponding image 
numbers catalogued for later identification. Manual focus was required to retain the same focal 
point throughout all image captures and a remote shutter release device was used to ensure stable 
images acquisition. Contrast was required between the growth medium and mycelia to produce 
an accurate margin selection for area measurement as well as to be able to discern the margin of 
the ruler demarcations using GIMP. Therefore, the location of the photos as well as the camera’s 
white balance, exposure, f-stop, and ISO, among other parameters, may need to be manually 
adjusted in order to attain consistent contrast between photo acquisitions. 
A photo of a ruler was used to set the initial focal point for the photo set as well as 
serving as a calibration device for determining the conversion factor during image analysis. The 
ruler was placed at the same height as the agar surfaces to be photographed, either by supporting 
it or by cutting the edges of a Petri dish to allow the ruler to be set into the Petri dish at the height 
of the agar. The image of the ruler was analyzed by measuring the number of pixels between two 
demarcations on the ruler that equaled a distance of one centimeter. 
To measure the area of radial mycelial growth, an area selection tool was used. The 
Fuzzy Selection tool is designed to select areas based on color similarity. The threshold was 
adjusted to change the degree to which similarly colored areas were selected. By increasing the 
threshold, a broader range of similar colors was selected, and conversely, by decreasing the 
threshold, the narrower range of similar colors was reduced. A Threshold of 10 to 20 worked 
well for the majority of image analyses. Selection of mycelial area produced an output of the 
number of pixels that comprised the selected area. Percent difference between test and control 
growth area could be calculated without a conversion to meters, however if a comparison was 
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desired in SI units, then a conversion was necessary. Using the conversion equation (Figure 3.2), 
the area in pixels2 was converted to mm2. 
 
 
Figure 3.2 Equation for calculating mycelial area from pixels of a digital photograph 
 
3.2.2 In Vitro Evaluation of Antifungal VOCs 
 
In vitro inhibition assays were conducted to evaluate the anti-P. destructans activity of 
VOCs with known antifungal activity. Select formulations were created and modified by the 
addition and subtraction of compounds, and manipulation of compound ratios, with the intent to 
enhance antifungal activity. In vitro testing was conducted with a broad range of VOCs and VOC 
formulations, and at different concentrations, to evaluate the degree of inhibition to mycelial 
growth and conidial germination of P. destructans, as per the methods of Cornelison et al. 
(2014). These results have facilitated development of effective treatment regimens for in vivo 
testing. 
Two exposure methods were used to assess the degree of inhibition caused by gaseous 
VOC exposure, with preparation similar between the methods. Each method required a 30 mm 
Petri dish containing SDA to have either 25 µl of conidia solution (106 conidia ml−1) spread on 
the surface or a mycelial plug inserted. To produce the mycelial plug, a 5 mm diameter agar core 
was removed from the fresh agar with a transfer tube (Spectrum Medical, SC, USA) and 
discarded. Then, a 5 mm diameter mycelial core was cut from a confluent mycelial lawn and 
placed into the empty core of each 30 mm Petri dish. 
(
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠 𝑖𝑛 𝑎𝑟𝑒𝑎
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑖𝑥𝑒𝑙𝑠 𝑝𝑒𝑟 𝑚𝑚
)
2
= 𝐴𝑟𝑒𝑎 𝑜𝑓 𝑚𝑦𝑐𝑒𝑙𝑖𝑎 𝑖𝑛 𝑚𝑚2 
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The first exposure method required each 30 mm Petri dish to be placed, without a lid, 
inside a larger 150 mm Petri dish, in addition to a watch glass containing an absorbent disc. Each 
disc had a specific amount of liquid VOC or VOC formulation dispensed into it. Each 150 mm 
Petri dish was then sealed with Parafilm and incubated at 15°C. 
The second exposure method required a sealed glove box of a known volume and a hot 
plate with a watch glass placed inside to evaporate a known quantity of VOC or VOC 
formulation. The amount of VOC or formulation required to produce a specific gaseous 
concentration was determined using equations derived from the ideal gas law (Figure 3.3). Glass 
jars containing the 30 mm Petri dishes were opened inside the glove box after evaporation and 
homogenization of the VOC or formulation, then sealed with Parafilm and incubated at 15°C. 
Controls were sealed and incubated without exposure to VOCs. All exposures and 
controls were performed in triplicate and examined several days post-inoculation to qualify spore 
germination and quantify growth area of exposed and unexposed mycelial plugs, to determine 
any significant differences in the quantity and rate of growths. 
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Figure 3.3 Equations for converting a desired gaseous concentration to a liquid volume 
 
Modification of VOCs and VOC formulations that demonstrated inhibition focused on 
incorporating other previously identified anti-P. destructans VOCs to enhance inhibitory activity 
(Cornelison et al. 2014). The discovery of highly effective and synergistic anti-P. destructans 
VOC formulations permitted lowering the effective dose of each compound while maintaining or 
enhancing inhibitory effects. VOC formulations chosen for continued testing with the dispersal 
system were required to undergo dispersal rate analysis in order to be accurately dispersed with 
the dispersal system utilizing the jet nebulizer. 
 
 
 
 
 
𝑉𝐼 = 𝑅 ×
𝑇
𝑃
               𝐴𝑃 =
𝑀
𝑉𝐼
× 𝑉𝐺                𝐴𝑇 =  𝐴𝑃 × 𝐶 
 
R = Gas Constant 8.2057338x10-2 (L atm K−1 mol−1) 
T = temperature (Kelvin) 
P = pressure (atm) 
M = molecular weight of the compound (g/mol) 
VI = volume of an ideal gas (m
3) 
VG = volume of headspace (m
3) 
AP = Amount to raise 1 ppmv (g) 
C = Desired concentration (ppmv) 
AT = Total amount (g) to attain desired concentration (C) in a known volume (VG) 
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3.3 Dispersal System Development 
 
3.3.1 Dispersal Characterization 
 
Volatile organic compounds will evaporate at different rates when exposed to varied 
environmental conditions and when used with different dispersal technologies. Investigating the 
factors that affect dispersal and evaporative efficiency among different dispersal technologies 
enables determination of an appropriate use of each technology as well as aiding in developing 
corrective measures to ensure consistent and accurate dispersal under diverse environmental 
conditions. Two different aerosolization technologies were studied, the jet nebulizer and rotary 
atomizer. 
 
3.3.1.1 Jet Nebulizer 
 
The jet nebulizer is an aerosolization technology developed for the medical industry to 
dispense respiratory therapy medications to patients in the form of an aerosol inhaled into the 
lungs. It produces a microscopic aerosol that permits efficient drug delivery through respiration. 
Of the three most common nebulizer technologies on the market, jet, vibrating mesh, and 
ultrasonic, the jet nebulizer was chosen for initial study because of its lower cost, simpler design, 
and greater resilience to clogging. It operated by pressurized air that is passed through a small jet 
aperture to produce a high-pressure airflow that disrupts a thin layer of fluid (Figure 3.4). The 
aerosol produced contains both large- and small-diameter droplets. A baffle deflects and returns 
the larger droplets to the reservoir to be recycled but permits the smaller droplets to be carried 
out of the nebulizer by the airflow. The small size of nebulizers makes them well suited for 
portable, small- to medium-scale applications. 
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Figure 3.4 Operational diagram of a jet nebulizer (Vecellio, 2006) 
 
Evaluation of the jet nebulizer was performed with an air chamber to analyze dispersal 
characteristics as well as investigate dispersal irregularities that may arise from conditions 
present in natural hibernacula. This evaluation required the development of a chamber that was 
both inert to gaseous VOC exposure and granted the ability to modify abiotic conditions. Direct 
headspace sampling from the chamber was conducted with a gas-tight syringe (Agilent, 
California, USA) and solid-phase micro-extraction (SPME) fibers (Supelco, Inc., Pennsylvania, 
USA). Analysis was carried out on an Agilent 7890A gas chromatograph connected to an 
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Agilent 5977A mass spectrometer (GCMS, Agilent, California, USA) to determine 
aerosolization rates, evaporative efficiency, and overall reproducibility. 
As compounds with different physical characteristics aerosolize at different rates, testing 
required empirically determining the rate of dispersal for treatment compounds in order to ensure 
accurate dispersal. Dispersal analyses enabled determination of a specific aerosolization rate for 
a specific compound or formulation. The results from air chamber headspace analyses were used 
to determine the dispersal rates of treatment formulations as well as further advance the 
mathematical functions and feedback mechanisms used to modulate the jet nebulizer and 
produce more accurate VOC dispersal. 
 
3.3.1.2 Rotary Atomizer 
 
 The Dyna-Jet L-30 rotary atomizer is an industrial-scale ultra-low volume (ULV) 
aerosolizer. The L-30 utilizes a rotary atomizer that produces aerosol from centrifugal force that 
propels liquid outward from the center of a high-speed rotating disc. As the liquid moves toward 
the edge of the disc, it spreads out and creates atomized droplets at the edge. The L-30 was 
chosen for analysis for its ability to operate fully on electric power, disperse large volumes, 
produce very low diameter aerosol droplets (90% below 24 µm median diameter), and operate 
quietly. The L-30 has several advantages over the jet nebulizer. In addition to being able to 
disperse larger volumes, it also utilizes a piston pump to dispense its fluid. This enables an 
absolute dispersal rate to be maintained, precluding the need to conduct a dispersal rate analysis 
for each VOC or formulation. 
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3.3.2 High-Frequency Acoustic Output 
 
Due to their nocturnal activity, bats have evolved the ability to navigate in darkness, 
which includes the ability to hear and echolocate in the ultrasonic range. The most sensitive 
range is between 15 kHz to 90 kHz, however some species have an extended range up to 200 
kHz (Adams and Pedersen, 2000). 
 Several different aerosolization technologies were powered to their respective operating 
specifications to have their acoustic output analyzed. An M500 ultrasonic microphone 
(Pettersson Elektronik, Sweden), with a parabolic cone to focus sound, was positioned 
approximately 5 feet from several dispersal devices during normal operation. Audio was sampled 
up to 500 kHz and recorded to a 16-bit raw WAV file. The frequency spectrum of the recording 
was analyzed with BatSound touch (Petterson Elektronik, Sweden) to produce spectrograms 
from 0 – 250 kHz. The usable range for this microphone is 10 – 190 kHz, therefore all 
spectrograms were limited to 200 kHz. 
 
3.4 Standard Gaseous Curve Development 
 
There exist a number of confounding factors that may affect the gaseous concentration of 
VOCs when dispersed in their liquid form during treatment studies. As such, gaseous 
concentrations were validated with the creation of standard curves that enabled quantification of 
a headspace sample of an unknown gaseous concentration. In order to produce a standard curve, 
both a sealed air space of a known volume and the ability to create a known gaseous 
concentration were required. 
 39 
 
Standards gaseous concentrations were prepared by evaporating a specific amount of 
pure VOC or formulation in a sealed glove box of a known volume. Amounts were calculated 
from the equations in Figure 3.3. An 80-watt direct current (DC) regulated power supply 
(Extech, New Hampshire, USA) was connected through the bulkhead port to a 12-volt DC 
Peltier device with a watch glass set on top of the heated surface. The heater was powered and 
limited to 12 volts and 1.5 amps, raising the temperature of the watch glass near 100°C. An 80 
mm 12-volt DC fan was used to circulate the air to homogenize the headspace. 
Several standard curves were produced from gaseous headspace samples, using two 
sampling methods: a gas-tight syringe (Agilent, California, USA) with direct-injection and solid-
phase micro-extraction (SPME) fibers (Supelco, Inc., Pennsylvania, USA) and thermal 
desorption. Initial standard curve development focused on method development and analysis 
technique, and therefore a high-purity sample of toluene was used. Subsequent standard curve 
developments focused on analyzing the B-23 formulation. All liquid amounts that were 
evaporated to produce a known gaseous concentration were calculated from the equations in 
Figure 3.3. Calculating the amount required to produce specific gaseous concentrations of the B-
23 formulation entailed calculating the required amount for each compound of the formulation, 
then adjusting each amount based on the percentage each contributed to the formulation. 
The first gaseous toluene standard curve was produced with a direct headspace sampling 
and injection using a GC gas-tight syringe. The concentration range was from 50 to 250 ppmv, at 
50 ppmv increments. An aliquot of toluene, in an amount calculated to produce a concentration 
of 50 ppmv, was pipetted onto a heated watch glass and allowed to evaporate and homogenize in 
a sealed glove box. A 100 µl headspace sample was extracted from the glove box through a 
bulkhead with a septum using a gas-tight GC syringe, and then manually injected into a GCMS 
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to analyze the sample. Separately, 50, 100, 150, 200, and 250 ppmv concentrations were 
produced in the glove box and analyzed with the GCMS, with each sample and analysis 
performed in triplicate. The GC method was programmed as follows: the injector port was held 
at 40°C in splitless mode, and the oven temperature was held at 30°C for 1 minute, then raised 
50°C min−1 to 150°C and held for 1 minute. The MS detector was programmed with a scan range 
of 37 - 94 m/z. Manual peak selection was performed on the resulting chromatograms and peak 
area was calculated for each trial of each concentration using MassHunter Qualitative Analysis 
(version B.07.00, Agilent, California, USA). 
The second gaseous toluene standard curve was produced with a direct headspace 
sampling technique using a polydimethylsiloxane divinylbenzene (PDMS-DVB) SPME fiber. 
The concentration range was from 25 to 125 ppmv, at 25 ppmv increments. An aliquot of 
toluene, in an amount calculated to produce a concentration of 25 ppmv, was pipetted onto a 
heated watch glass and allowed to evaporate and homogenize in a sealed glove box. The SPME 
fiber was injected through the bulkhead with a septum and exposed to the headspace for 5 
minutes, then thermally desorbed in the GC inlet for analysis. Separately, 50, 75, 100, and 125 
ppmv concentrations were produced in the glove box and analyzed with the GCMS, with each 
sample and analysis performed in triplicate. The GC method was programmed as follows: the 
injector port was held at 40°C in splitless mode and the oven temperature was held at 30°C for 1 
minute, then raised 50°C min−1 to 150°C and held for 1 minute. The MS detector was 
programmed with a scan range of 37 - 94 m/z. Manual peak selection was performed and peak 
area was calculated for each trial of each concentration using MassHunter Qualitative Analysis. 
A standard curve for the B-23 formulation was produced with a direct headspace 
sampling technique using a PDMS-DVB SPME fiber. The concentration range was from 100 to 
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500 ppmv, at 200 ppmv increments. An aliquot of the B-23 formulation, in an amount calculated 
to produce a concentration of 50 ppmv, was pipetted onto a heated watch glass and allowed to 
evaporate and homogenize in a sealed glove box. The SPME fiber was injected through the 
bulkhead with a septum and exposed to the headspace for 5 minutes, then thermally desorbed in 
the GC inlet for analysis. Separately, 100, 300, and 500 ppmv concentrations were produced in 
the glove box and analyzed with the GCMS, with each sample and analysis performed in 
triplicate. The GC method was programmed as follows: the injector port was held at 250°C with 
a 20:1 split and the oven temperature was held at 40°C for 1 minute, then raised 10°C min−1 to 
250°C and held for 1 minute. The MS detector was programmed with a scan range of 35 - 360 
m/z. Manual peak selection was performed on the primary and secondary peaks and peak areas 
were calculated for each trial of each concentration using MassHunter Qualitative Analysis. 
 
3.5 Bat Toxicological Histopathological Evaluation 
 
To determine any negative toxicological effects from an effective anti-P. destructans 
formulation, a study was conducted in which uninfected tri-colored bats (Perimyotis subflavus) 
(n=37) were collected and housed at 8°C to induce hibernation, then exposed to a 10 ppmv 
gaseous VOC formulation with the treatment device. The VOC formulation consisted of 2-ethyl-
1-hexanol, benzaldehyde, and decanal in a 1:1:1 molar ratio. This dispersal regimen was repeated 
every 24 hours, for 42 days. A random segment of both control and test groups were removed at 
days 10 (acute exposure, n=12), 42 (chronic exposure, n=12), and 42 with 8 days of euthermic 
temperatures (chronic exposure and post-euthermia, n=13), euthanized, and subject to a full 
necropsy with particular interest in the condition of respiratory tissues. 
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Thirty-seven formalin-fixed bats were stained with hematoxylin and eosin before being 
examined for lesions. All tissues were trimmed into histology cassettes. Bats numbered 1 
through 12 were from the acute exposure group (10-day trial), with the first 6 exposed to VOCs 
and the last 6 controls. Bats numbered 13 through 24 were from the chronic exposure group (42-
day trial), with the first 6 exposed to VOCs and the last 6 controls. Bats numbered 25 through 36 
were from the post-hibernation group (42-day trial, followed by 8 days euthermia), with the first 
six exposed to VOCs and the last six controls. Bat numbered 37 was from the post-hibernation 
group exposed to VOCs. 
 
3.6 Treatment at Black Diamond Tunnel 
 
Black Diamond Tunnel is a railway tunnel in Clayton, Georgia that began construction in 
the 1850s. Construction was put on hold during the Civil War and was never resumed, leaving 
the tunnel uncompleted. The tunnel has one opening that is approximately 4.4 meters in width 
and 5.4 meters in height at the entrance. It extends 423 meters straight into the rock mountainside 
and at a 1° downward slope. As a consequence of no drainage, water has flooded the entire 
length of the tunnel, necessitating the use of a boat to safely gain access. 
The tunnel has historically been the site of the largest tri-colored bat (Perimyotis 
subflavus) population known to Georgia, with population surveys consistently yielding 
approximately 5,000 each year, prior to 2014. However, since WNS was first detected in 2013, 
the population has undergone precipitous decline. Within 3 years of detecting WNS in 2013, the 
population has decreased 95%, with the latest pre-treatment survey yielding 220 tri-colored bats 
as of March, 2016 (Figure 3.5). 
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This is the site of an ongoing development of a VOC-based WNS mitigation effort using 
the L-30 to distribute doses of the B-23 formulation. Through The Conservation Fund and the 
Transcontinental Gas Pipeline Company, we have been awarded a $200,000 grant to develop an 
integrated disease management (IDM) system over the next 4 years, with a goal of increasing 
survivorship of bat populations affected by WNS at Black Diamond Tunnel. 
 
 
Figure 3.5 Tri-colored bat population counts at Black Diamond Tunnel from 2010 to 2016 
 
To prepare the site for treatment, infrastructure was constructed inside and outside of the 
tunnel (Figure 3.6). A platform was constructed to secure a battery-powered capstan winch 
(Powerwinch 300; Powerwinch, Colorado, USA), to enable extension and retrieval of the L-30 
that has been secured to a 10-foot flat-bottomed boat. A pulley was attached to a buoy and 
secured near the rear of the tunnel with 20 feet of 0.25-inch diameter polypropylene rope to 100 
pounds of weight, acting as a mooring anchor. A length of 600 meters of 0.25-inch diameter 
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polypropylene rope was fed though the pulley and the free ends were attached to the bow and 
stern of the boat. With the open loop wrapped around the capstan winch drum, the vessel was 
able to be moved in and out of the tunnel at will by actuating the capstan winch at the entrance. 
Demarcations were produced along the rope every 12 meters, permitting accurate determination 
of the position of the boat inside the tunnel. This also allowed the speed of the boat and L-30 to 
be measured at 26 meters minute−1, which verified the rated speed of the winch. 
 
 
Figure 3.6 Diagram of the infrastructure at Black Diamond Tunnel 
 
An initial target treatment concentration of 300 ppmv was chosen, as this was the 
minimal amount determined by in vitro studies to elicit significant P. destructans inhibition. 
Using the equations from Figure 3.3, and an estimated tunnel volume of 5,300 m3, 6.772 liters of 
the B-23 formulation was calculated as the amount required to be dispersed to attain a 300 ppmv 
maximum homogeneous concentration, if 100% volatilization were to occur. The L-30 was 
calibrated to disperse at 200 ml minute−1, rendering a total run time of 33.85 minutes to disperse 
6.772 liters. 
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The vessel was sent into the tunnel 300 meters, the furthest point at which safe operation 
could be achieved without risk of the L-30 coming into contact with the ceiling, before beginning 
dispersal. With a boat movement speed of 26 meters minute−1, traversing 300 meters would 
require 11.54 minutes. With the dispersal requiring a longer duration than the boat retrieval, 
22.31 minutes would need to be accounted for. After dispersal began, the vessel was retrieved 
using the capstan winch, stopping at every 12-meter demarcation for approximately 56 seconds. 
The addition of these timed stops enabled the retrieval to match the dispersal duration, promoting 
an even dispersal throughout the tunnel length. The entrance of the tunnel was not sealed for any 
of the three treatments during the first winter treatment, in order to allow any bats to freely leave 
the tunnel and to permit a visual assessment of bat disturbance. 
Water samples were obtained at the entrance of the tunnel, pre-treatment and up to 1 hour 
post-treatment. Air samples were obtained 150 meters into the tunnel, pre-treatment and up to 1 
hour post-treatment. Air and water samples were also obtained 7 days post-treatment at the same 
locations, which underwent concentration analyses to determine the environmental fate of the B-
23 formulation. The first winter treatments were conducted on November 4, 2016, December 2, 
2016, and January 6, 2017. Bat population surveys were conducted prior to the first and second 
treatments, as well as post-winter, on February 28, 2017. 
 
4 RESULTS 
4.1 Antimicrobial Susceptibility 
 
4.1.1 Quantification of Filamentous Fungi Growth 
 
Area measurements derived from ruler and digital analyses were not shown to differ 
significantly when small areas (approximately 20 mm2 or less) were measured. However, as 
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areas increased, the differences between them increased significantly. Ruler measurements 
consistently yielded smaller area calculations, resulting in larger calculated percent inhibitions 
(Table 4.1). 
 
Table 4.1 Comparison of ruler and digital measurements of mycelial growth area 
Comparison of area from ruler and digital measurements (measured in mm2) 
Method Ruler Digital Ruler Digital Ruler Digital 
DPI 8 8 11 11 13 13 
Plug 1 14.19 10.73 27.54 43.81 46.66 86.47 
Plug 2 13.55 13.4 22.36 37.52 44.51 83.02 
Plug 3 20.24 19.68 43.1 47.62 57.93 100.28 
Plug 4 13.55 11.95 19.54 29.12 31.42 74.94 
Plug 5 20.24 19.26 34.63 48.62 62.88 106.02 
       
Comparison of percent reduction of growth from ruler and digital measurements (measured in mm2) 
Method Ruler Digital Ruler Digital Ruler Digital 
DPI 8 8 11 11 13 13 
Plug 1 66.40% 73.80% 59.50% 44.30% 45.30% 29.90% 
Plug 2 67.90% 67.30% 67.10% 52.30% 47.90% 32.70% 
Plug 3 52.10% 52.00% 36.60% 39.40% 32.10% 18.70% 
Plug 4 67.90% 70.80% 71.30% 63.00% 63.20% 39.20% 
Plug 5 52.10% 53.00% 49.10% 38.20% 26.30% 14.00% 
 
This discrepancy between the accuracy of measurement methods is primarily due to two 
factors. First, as area increases, miscalculations produce a greater error. For instance, an error of 
1 mm when measuring a radius of 5 mm produces a minimum area of 50.3 mm2 and maximum 
of 113.1 mm2, with a difference of 62.8 mm2. An error of 1 mm when measuring a radius of 10 
mm yields a minimum area of 254.5 mm2 and maximum of 380.1 mm2, with a difference of 
125.6 mm2.  
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Second, there is higher resolving power when measuring with digital photography than 
with the human eye. A resolution of a photograph is determined by how many pixels are present 
in the measured area, whereas the resolution of a ruler is determined by the number of 
delineations. For instance, it is not uncommon for the resolution of 1 mm of a digital photograph 
to be 200 pixels, or 200 discernable units per 1 mm. However, a ruler may have only 4 
discernable units per mm. Using the same example above, a circle with a radius of 5 mm would 
yield an error of 15.7 mm2 using a ruler with 4 units per mm, yet only 0.3 mm2 from a digital 
photograph with 200 units per mm. 
 
4.1.2 Exposure Assays with Six Previously-Described VOCs 
 
The degree of inhibition each VOC induced was calculated by comparing the growth area 
from the exposed mycelial plugs to the unexposed control plugs, at both 15°C (Figure 4.1) and 
4°C (Figure 4.2). 
At 15°C, P. destructans displayed a range of susceptibility to the tested VOCs. With 
exposure to 30 μl of each VOC, partial inhibition of mycelial growth was observed in the 
presence of decanal, which exhibited 68% inhibition after 11 days post-inoculation (DPI), and 
complete inhibition with all others. With exposure to 3.0 μl of each VOC, partial inhibition of 
mycelial growth was observed in the presence of decanal and N-N-dimethyloctylamine, both 
exhibiting ≥ 20% inhibition after day 7 DPI and ≥ 10% inhibition after 11 DPI, and complete 
inhibition with all others. With exposure to 0.3 μl of each VOC, partial inhibition of mycelial 
growth was observed with 2-ethyl-1-hexanol, benzaldehyde, benzothiazole, decanal, and 
nonanal, and stimulated growth was observed with exposure to N-N-dimethyloctylamine. 
Decanal induced the least inhibition, from 0% after 7 DPI to 7% after 11 DPI. 2-ethyl-1-hexanol 
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induced the greatest inhibition, with 52% after 7 DPI to 60% after 11 DPI. N-N-
dimethyloctylamine stimulated growth, from 24% after 7 DPI to 9% after 11 DPI. Growth plots 
can be seen in Figures 4.1a, 4.1b, and 4.1c. 
At 4°C, exposure to 30 μl and 3.0 µl aliquots of each VOC resulted in complete 
inhibition of P. destructans mycelial growth. With exposure to 0.3 μl of each VOC, P. 
destructans displayed partial inhibition with all VOCs. Benzaldehyde induced the least 
inhibition, at 4% after 19 DPI and 8% after 36 DPI. Decanal induced the greatest inhibition, with 
100% after 19 DPI to 99% after 36 DPI.  
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Inhibition assays with Pseudogymnoascus destructans exposed to 30.0 µl (a), 3.0 µl (b), and 0.3 µl (c) of 
each of 6 VOCs and incubated at 15°C. Absence of any of the 6 VOCs from a graph indicates there was 
no growth when exposed to that VOC.  
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Figure 4.1 Growth of Pseudogymnoascus destructans exposed to single VOCs at 15°C 
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Inhibition assays with Pseudogymnoascus destructans exposed to 0.3 µl of each of 6 VOCs and 
incubated at 4°C. Absence of decanal from the graph indicates there was no growth when exposed to 
that VOC.  
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Figure 4.2 Growth of Pseudogymnoascus destructans exposed to single VOCs at 4°C 
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4.1.3 Exposure Assays with VOC Formulations 
 
Three VOC formulations comprised of two VOCs were observed to promote significant 
synergistic inhibition of P. destructans mycelial growth (Figure 4.3). Those include 2-ethyl-1-
hexanol and benzaldehyde, 2-ethyl-1-hexanol and nonanal, and 2-ethyl-1-hexanol and decanal. 
The greatest difference between the inhibitions elicited by the formulation vs. the combined 
inhibitions of each VOC occurred after 6 DPI with 2-ethyl-1-hexanol and benzaldehyde, 14 DPI 
with 2-ethyl-1-hexanol and nonanal, and 14 DPI with 2-ethyl-1-hexanol and decanal. Growth 
areas of P. destructans mycelial plugs exposed to each VOC and formulation are provided in 
Figure 4.3 and percent inhibition was calculated in Figure 4.4. 
Two VOC formulations comprised of three VOCs were observed to promote significant 
synergistic inhibition of P. destructans mycelial growth. Those include a formulation of 2-ethyl-
1-hexanol, benzaldehyde, and decanal, and a formulation of 2-ethyl-1-hexanol, nonanal, and 
decanal. Growth areas of P. destructans mycelial plugs exposed to each VOC and formulation 
are provided in Figure 4.5 and percent inhibition in Figure 4.6. 
The B-23 formulation was observed to elicit significant inhibition of P. destructans 
mycelial growth area following a 24-hour gaseous exposure of 500 ppmv, after 7 DPI (p=0.025) 
and 11 DPI (p=0.009). Growth area of P. destructans mycelial plugs following a 24-hour 
exposure to various gaseous concentrations of the B-23 formulation are provided in Figure 4.7 
and percent inhibition was calculated in Figure 4.8. 
 52 
 
 
Figure 4.3 Pseudogymnoascus destructans area growth when exposed to 2 VOCs 
A comparison of Pseudogymnoascus destructans mycelial growth while exposed to two pure VOCs and a 
formulation of those VOCs. All VOC and formulation exposures were 4 µmol (Cornelison et al., 2014). 
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Figure 4.4 Pseudogymnoascus destructans inhibition when exposed to 2 VOCs 
A comparison of Pseudogymnoascus destructans radial mycelial growth inhibition while exposed to two 
pure VOCs and a formulation of those VOCs. All VOC and formulation exposures were 4 µmol 
(Cornelison et al., 2014). Negative inhibition indicated stimulated growth. 
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Figure 4.5 Pseudogymnoascus destructans area growth when exposed to 3 VOCs 
A comparison of Pseudogymnoascus destructans mycelial growth while exposed to two pure VOCs and a 
formulation of those VOCs. All VOC and formulation exposures were 4 µmol (Cornelison et al., 2014). 
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A comparison of Pseudogymnoascus destructans radial mycelial growth inhibition from exposure to three 
pure VOCs and a formulation of those VOCs. All VOC and formulation exposures were 4 µmol 
(Cornelison et al., 2014). Negative inhibition indicated stimulated growth. 
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Figure 4.6 Pseudogymnoascus destructans inhibition when exposed to 3 VOCs 
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Figure 4.7 Pseudogymnoascus destructans growth area following exposure to B-23 
A comparison of Pseudogymnoascus destructans mycelial growth following a 24-hour exposure to the B-
23 formulation at different gaseous concentrations.  
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Figure 4.8 Pseudogymnoascus destructans inhibition following exposure to B-23 
A comparison of Pseudogymnoascus destructans radial mycelial growth inhibition following a 24-hour 
exposure to the B-23 formulation at different gaseous concentrations. 
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Table 4.2 Summary of the differences between the jet nebulizer and rotary atomizer 
 Jet Nebulizer Rotary Atomizer 
Droplet Size (diameter) Extremely Small (≤ 5 µm) Small (≤ 20 µm) 
Dispersal Rate Slow (20 ml hour−1) Fast (12,000 ml hour−1) 
Coverage Area Small (2 kg) Medium to Large (68 kg) 
Acoustic Frequency Output ≥ 200 kHz ≤ 50 kHz 
Physical Size Small Large 
Cost Inexpensive Expensive 
A summary of the major differences between the two different aerosolization technologies used 
in this study, a jet nebulizer and a rotary atomizer. 
 
4.2.1 Dispersal Characterization 
 
4.2.1.1 Jet Nebulizer 
 
The Pari Trek S nebulizer relies on constant air pressure from a pneumatic pump to 
maintain a constant dispersal rate. Maintaining this pressure requires a constant voltage and 
current from the power supply. If power diminishes, the dispersal rate decreases, and if constant 
power cannot be supplied, such as during battery depletion, this needs to be compensated in 
some way to maintain accurate dispersal and reach the target concentration. This power 
compensation has been addressed in two ways. 
The first method relies on providing an initial power duty cycle below 100%, and in the 
event of diminishing power, increasing the duty cycle to maintain output. Duty cycle is the 
percentage of time in which a signal or system is active. For instance, a 50% duty cycle would 
activate the nebulizer’s pneumatic pump for an equal duration of time as it is off (50% of the 
time on, 50% of the time off). Typically, with electric motors, duty cycles are controlled by pulse 
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width modulation (PWM). PWM is a technique to rapidly switch the power on and off at a fast 
rate (typically hundreds of times per second). By controlling the duration of the on and off pulses 
by PWM, the amount of power output can be controlled without negatively affecting the 
performance of the motor. As a battery drains, the electrical voltage and current supplied to the 
pneumatic pump decrease, slowing the rotational speed of the motor shaft used to actuate the 
pump, resulting in a drop in output pressure. If the initial duty cycle of the pump is less than 
100%, the duty cycle may be increased in order to compensate for diminished power and to 
maintain a constant output pressure. Because the initial duty cycle is less than 100%, this system 
will be required to run for a longer duration to attain the same dispersal amount as a system that 
begins with an initial duty cycle of 100%. 
The second method relies on an initial power duty cycle of 100%, and the use of a sensor 
to measure the pump output pressure. With this method, the pump will experience an 
unavoidable but expected pressure drop as power diminishes, however, because the pneumatic 
pump’s pressure is monitored with a sensor, the dispersal duration can be increased appropriately 
in order to attain the final target concentration. 
 Additionally, different compounds were discovered to disperse at different rates. 
Therefore, the dispersal rate for each compound used with the jet nebulizer was required to be 
empirically determined by performing a dispersal rate analysis. The results of two dispersal 
analyses are shown in Figure 4.9.  
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Figure 4.9 Dispersal rates of two compounds using a jet nebulizer 
The dispersal rate of ethanol (blue) and a VOC formulation not containing ethanol (green). 
 
4.2.1.2 Rotary Atomizer 
 
The L-30 rotary atomizer utilizes a ceramic piston pump designed for precise fluid 
metering (flow rate). Flow rates were calibrated by adjusting the pump head position, changing 
the piston stroke length and, in turn, the fluid flow rate. Repeated analyses indicated a consistent 
flow rate, as verified by the manufacturer reproducible precision of 0.5% error (Fluid Metering 
Inc., New York, USA). Many of the difficulties encountered with attaining accurate dispersal 
rates with the nebulizer have been overcome by utilizing this technology, which maintains an 
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conditions. However, similar to the nebulizer, battery depletion may diminish the ability of the 
pump to maintain the target flow rate, necessitating compensation if an appropriate power source 
is not utilized. 
 
4.2.2 High-Frequency Acoustic Output 
 
 Several distribution technologies were analyzed for their acoustic output. The three 
technologies tested include the Trek S pneumatic nebulizer, the Cyclone and Hurricane blower 
aerosolizers (Dyna-fog, Illinois, USA), and the L-30 rotary atomizer. There was considerable 
variance in both acoustic frequencies and amplitudes produced between each type (Figure 4.10). 
The Trek S produced considerably higher frequencies than any other device, due mainly to the 
design of the jet nozzle and high-pressure required to aerosolize the fluid. The Hurricane and 
Cyclone also produced high frequencies but were more consistent across the frequency spectrum 
and at a lower amplitude. The L-30 produced the smallest frequency range as well as the lowest 
amplitude of all devices tested. 
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Samples taken from the Pari Trek S (a), Dyna-fog Cyclone (b), Dyna-fog Hurricane (c), and Dyna-fog L-
30 (d) aerosolizers, measuring 0 to 200 kHz, 0 to −65 db. Decibels scaled blue (0 db, loud) to yellow 
(−60 db, quiet), with white considered silent. 
 
 
 
 
Figure 4.10 Spectrograms of audio samples acquired from several aerosolization technologies 
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4.3 Standard Gaseous Concentration Curves 
 
A standard curve was produced for a single, pure compound to become familiar with 
curve creation methodologies and GCMS method development, before developing a standard 
curve for the complex B-23 formulation. Toluene was selected to begin initial curve 
development, with two sampling methods used to compare the accuracy of each. 
The curve produced using the gas-tight syringe sampling method produced high 
variability between successive measurements (Figure 4.11). The curve produced using the SPME 
fiber sampling method yielded less variability between successive measurements and produced a 
greater fit to a linear trend (Figure 4.12). 
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Figure 4.11 Standard curve of toluene using gas-tight syringe headspace sampling 
A standard curve derived from the primary peak of a GC chromatogram of toluene, detected by GCMS-
headspace analysis using gas-tight syringe headspace sampling and direct injection methods. 
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Figure 4.12 Standard curve of toluene using SPME headspace sampling 
A standard curve derived from the primary peak of a GC chromatogram of toluene, detected by GCMS-
headspace analysis using SPME headspace sampling and thermal desorption methods. 
 
A standard curve of the B-23 formulation was produced from 100 ppmv to 500 ppmv, in 
200 ppmv increments. Primary and secondary peaks of the chromatogram appeared at retention 
times of 8.3 minutes and 7.6 minutes, respectively (Figure 4.13). Manual peak selection was 
performed for the primary and secondary peaks of the formulation and the peak areas were 
calculated using MassHunter Qualitative Analysis. The average, standard deviation, and error 
was calculated for each set of trials and plotted to a graph (Figure 4.14). 
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Figure 4.13 Chromatogram of the B-23 formulation 
The first 10.5 minutes of the chromatogram produced by SPME desorption of the B-23 formulation. The 
primary peak had a retention time of 8.3 minutes and the secondary peak had a retention time of 7.6 
minutes. 
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Standard curves derived from the primary (b) and secondary (a) peak areas of several incremental gaseous 
concentrations of B-23, detected by GCMS-headspace analysis. 
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Figure 4.14 Standard curves of the primary and secondary peaks of the B-23 formulation 
 68 
 
4.4 Bat Toxicological and Histological Evaluation 
 
A toxicological evaluation has been conducted with a prototype system utilizing the jet 
nebulizer, in which torpid tri-colored bats (Perimyotis subflavus) were exposed to an anti-P. 
destructans VOC formulation that demonstrated significant in vitro efficacy (Cornelison et al., 
2014). Necropsies were conducted and described by Kevin Keel, DVM, and revealed neither 
acute nor chronic treatment groups exhibited significant negative toxicological effects when 
compared to controls (Tables 4.3 and 4.4). Ocular tissues, the respiratory tract, heart, liver, 
kidneys and skin were of particular interest for the toxicity assessment and were generally 
available for examination. Analysis of post-hibernation weight found that weight loss was 
greater within the test group than the control group. 
Some degree of autolysis or putrefaction was evident in ten of the bats examined. Four of 
the samples (23, 25, 32 and 35) were affected severely enough to inhibit complete evaluation of 
the tissues. Two bats (5 and 32) had a mild conjunctivitis and surface bacteria were associated 
with the lesion of bat 32. Bat 27 had a mild acute keratitis in which neutrophils infiltrated the 
corneal stroma. The cause of the ocular inflammation was uncertain but was likely due to 
bacteria or a contact irritant. Two bats (13 and 17) had mild to moderate accumulations of 
neutrophils in the airway epithelium and in the lumen of bronchioles, bronchi, and/or trachea; 
however, microorganisms were not evident. This lesion could have been due to a respiratory 
irritant, but the absence of a visible pathogen is not enough to rule out a viral or bacterial 
etiology. Three bats (6, 9 and 34) had an acute interstitial pneumonia. As with the 
bronchitis/tracheitis, no bacteria were evident, therefore the etiology was uncertain. 
The epithelium of the trachea and large airways, in nearly all samples, had some degree 
of cytoplasmic rarefaction or swelling. This could have been a postmortem artifact but it was not 
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clearly correlated with the degree of autolysis. The change was most significant in sample 9. 
Sample 33 had minimal cytoplasmic changes. If it was real, it could have been due to the 
excessive accumulation of fluid in the epithelial cells. 
Many of the animals had peracute hemorrhage or edema of the lungs. This may have 
been due to euthanasia. One bat (18) had abundant blood within the GI tract and some of this 
appeared to have been digested. The source of the blood was not identified, but its appearance 
suggested swallowing of blood some time before death or hemorrhage into the anterior portion of 
the gastrointestinal tract.  
The superficial keratinized layers of the skin on the patagium were generally elevated in 
the bats. This was not correlated with autolysis of other tissues and it may have been a normal 
postmortem change, or it may have occurred due to high humidity and softening of the tissue. 
One bat (14) had small fungal elements in hair follicles of the muzzle, which were most 
consistent with dermatophytosis. 
Four bats had mild to moderate coccidiosis (possibly Eimeria sp.), but these were not 
associated with significant inflammation. One bat (17) had mild, acute, superficial, segmental 
enteritis with adherent bacteria. The etiology was uncertain, but the changes suggested bacterial 
enteritis. Three bats (16, 24 and 34) had mild acute colitis of unknown etiology. Two additional 
bats (18 and 29) had mild acute colitis, and the inflammatory infiltrates were intimately 
associated with large fungal hyphae or cystic structures in the mucosal epithelium or lamina 
propria. Some of the cystic structures directly gave rise to the fungal hyphae.   
The pancreatitis in bat 30 was very unusual but was probably incidental to any of the 
treatments, as this was the only observed case. The other lesions listed were also considered 
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incidental. Most lesions (e.g. trematodiasis, coccidiosis) were probably reflective of the source 
population. 
 
Table 4.3 Tissues examined from each bat 
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This table identifies the test group each bat belonged to as well as the specific tissues examined for each 
bat. Produced by Kevin Keel, DVM.  
 71 
 
Table 4.4 Summary of tissues from bats 1 through 37 that tested positive 
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This table identifies the test group each bat belonged to as well as any abnormal conditions detected for 
each bat. Produced by Kevin Keel, DVM. 
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4.5 Treatment at Black Diamond Tunnel 
 
Laser measurements were obtained for the height and width of the tunnel at several points 
while traversing the length of Black Diamond Tunnel on a boat (Figure 4.15). Due to the 
variability of boat movement speed, distances between measurements were unable to be 
accurately determined, therefore volume calculations were conducted with the assumption that 
measurements were at evenly spaced intervals. Three methods were used to calculate the air 
volume in the tunnel: segments of the raw data (Figure 4.15), segments from linear trends of the 
raw data (Figure 4.16), and segments from 3° polynomial trends of the raw data (Figure 4.17). 
The Airspace volumes calculated, including averages and standard deviations, are in Table 4.5. 
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Figure 4.15 Two sets of the dimensional measurements of Black Diamond Tunnel 
Two sets of measurements were obtained with a digital laser measurer of the height and width of Black 
Diamond Tunnel while traversing from the entrance to the end (a) and from the end to the entrance (b). 
Effort was made to take measurements at consistent intervals. 
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Figure 4.16 Linear trend of the dimensional measurements of Black Diamond Tunnel 
A linear trend was calculated for the height and width measurements from the entrance to the end (a) and 
from the end to the entrance (b), to produce a best-fit line for calculating the estimated volume of the 
tunnel. 
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Figure 4.17 Polynomial trend of the dimensional measurements of Black Diamond Tunnel 
A third degree polynomial trend was calculated for the height and width measurements from the entrance 
to the end (a) and from the end to the entrance (b), to produce a best-fit line for calculating the estimated 
volume of the tunnel. 
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Table 4.5 Area calculation of Black Diamond Tunnel using three calculation methods 
Calculation 
Method 
Entrance 
to End 
End to 
Entrance 
Average 
Standard 
Deviation 
Minimum Maximum 
Segments 4657 6007 5332 955 4377 6287 
Linear Trend 5207 6490 5849 907 4942 6756 
Polynomial Trend 4615 7361 5988 1942 4046 7930 
Three calculation methods were employed to determine the volume of Black Diamond Tunnel, using two 
data sets (Entrance to End and End to Entrance). The average, standard deviation, minimum, and 
maximum volumes were calculated with each of these methods using both data sets. All values are 
volumes, represented in cubic meters (m3). 
 
An initial bat population survey on November 4, 2016, prior to the first treatment, yielded 
206 tri-colored bats. During the November 4 treatment, no bats were observed arousing or 
leaving the tunnel. B-23 was undetectable by GCMS in post-treatment water samples. Analysis 
of air samples obtained 1-hour post-treatment yielded several chromatographic peaks that were 
in agreement with the 300-ppmv gas standard (Figure 4.18); however, concentration varied. 
GCMS analysis of the 7-day post-treatment air samples did not detect any compound of the B-23 
formulation. 
Prior to the second treatment on December 2, 2016, a bat population survey was 
conducted that yielded a count of 216 tri-colored bats. Additionally, all bats appeared healthy, 
with no visual symptoms of WNS present at that time. It was also observed that many of the bats 
were roosting toward the rear of the tunnel. This second treatment was also conducted without 
observing any bat arousal or aversion, either during or after treatment. Air and water sample 
analyses were similar to the samples following the first treatment. A bat population count was 
not obtained prior to the January 6, 2017 treatment, but air and water samples were acquired, 
with GCMS analyses yielding similar results to prior treatments. 
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Figure 4.18 Chromatograms of a gaseous standard (black) and post-treatment at BDT (red) 
Air samples following treatment at Black Diamond Tunnel were analyzed with a GCMS to yield a 
chromatogram (red) that was compared to the chromatogram of a 300-ppmv gaseous standard of B-23 
(black). 
 
 A bat population survey was conducted February 28, 2017, which yielded a count of 152 
bats. It was also noted that the majority of bats were roosting further back into the tunnel and, of 
the bats that were there, did not appear to present severe symptoms of infection. The most 
current population statistics for the past 8 years at Black Diamond Tunnel is illustrated in Figure 
4.19. 
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Figure 4.19 Tri-colored bat population counts at Black Diamond Tunnel from 2010 to 2017 
Population change at Black Diamond Tunnel, with population counts in orange (left axis) and percent 
change from the previous year in blue (right axis). 
 
 
5 CONCLUSIONS 
5.1 Post-harvest Loss Due to Fungal Decay 
 
Fungal decay of fruits and vegetables accounts for a significant portion of post-harvest 
losses worldwide (Tripathi and Dubey, 2004; Parfitt et al., 2010). Although the degree to which 
post-harvest disease and spoilage by microorganisms contribute to global food waste has been 
difficult to accurately quantify, it is largely agreed that reducing these losses and increasing 
shelf-life is essential to preserving our food supplies for current and future generations (Parfitt et 
al., 2010). 
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The use of chemical fungicides is currently the most common method for controlling post-
harvest fungal disease and contamination. However, two major concerns exist with the use of 
these fungicides: residues that may negatively affect the environment and human health, and the 
development of resistance by the pathogen. These concerns have prompted many to seek 
alternatives to this method of treatment, with several areas of research emerging with alternative 
strategies for managing fungal contamination and disease. 
The use of antagonistic microorganisms has shown great potential for controlling disease 
and spoilage (Wilson et al., 1991; Weisskopf, 2013). Another emerging treatment method has 
been to strengthen the host defense mechanisms with the use of chemical compounds that induce 
or stimulate disease resistance in the host (Yao and Tian, 2005; Weisskopf, 2013). The use of 
these biologically-active natural products has begun to receive attention as a viable alternative to 
current synthetic fungicides because of their low toxicity (Wilson et al., 1991; Tripathi and 
Dubey, 2004; Weisskopf, 2013). These methods are very promising for enhancing food 
preservation and the more we understand about these complex interactions, the better we will be 
to develop solutions to disease, spoilage, and contamination. 
 
5.2 Antifungal Volatile Organic Compounds 
 
The use of biologically-derived VOCs has been shown to have great potential for both 
controlling microbial growth and stimulating natural plant defense mechanisms. The coevolution 
of soil microbiota, plant-associated endophytes, and fungal pathogens have produced 
mechanisms ideally suited for the complex ecology of their environments. The long-term 
efficacy of low quantities of VOCs suggests the potential of these compounds for in situ 
application in the treatment and suppression of fungal food spoilage and disease (Cornelison et 
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al., 2013). Additionally, the development of synergistic formulations supports a theory of soil-
based fungistasis as a source of potential control agents, as VOC mixtures are likely responsible 
for the observed fungistatic activity of many suppressive soils. The evaluation of microbially-
derived VOCs has expanded the pool of potential control agents and has led to the production of 
several patentable VOC formulations with significant anti-P. destructans activity (Cornelison et 
al., 2013, Gabriel and Cornelison, 2014). The availability of volatile formulations for control of 
P. destructans growth could prove to be a powerful tool for wildlife management agencies, if 
effective application methods can be established. 
The typical low level of antimicrobial VOCs produced in natural hosts and the significant 
antagonistic activity observed at these low levels is promising. The contact-independent activity 
of antagonistic VOCs has several advantages over topical and oral, contact-dependent, treatment 
options that have been shown to be effective at inhibiting the growth of pathogens. Contact-
independent antagonism allows for the potential treatment of many individuals with a single 
application and facilitates uniform exposure, reducing the potential for unaffected microbial 
refugia on the host that may facilitate re-colonization once the inhibitory compound has been 
removed or degraded. 
Interestingly, several compounds that stimulated P. destructans growth when exposed 
singly were found to synergistically inhibit growth when used as a component of a formulation, 
avowing to the unpredictability of VOC formulation development. Also worth noting, is as more 
compounds are added to the testing pool, the number of possible combinations to produce a 
formulation increase dramatically (Table 5.1). Furthermore, there are several challenges to 
developing antimicrobial susceptibility assays when moving from traditional media-based 
methods to gaseous headspace methods. Therefore, formulation development is often both 
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laborious and unpredictable, requiring extended periods of time to set up each assay and 
necessitating the testing of every possible combination to discover synergistic inhibitory 
formulations. It may be beneficial for future investigations to seek to streamline the 
methodologies of these assays in order to increase the speed of the formulation screening 
process. 
 
Table 5.1 Combinations of several compounds in formulations of two and three compounds 
# of compounds Formulations with 2 compounds Formulations with 3 compounds 
4 12 24 
6 30 120 
8 56 336 
10 90 720 
12 132 1320 
14 182 2184 
16 240 3360 
 
The contact-independent activity of antagonistic VOCs has several advantages over 
topical and oral, contact-dependent, treatment options that have been shown to be effective at 
inhibiting the growth of P. destructans in previous studies (Hoyt et al. 2015). The typical low 
level of antimicrobial VOCs produced in natural hosts and the significant antagonistic activity 
observed at these low levels is promising. 
 
5.3 Novel Fungal Management Strategies 
 
In order to develop an effective disease management strategy, concurrent development of 
both a treatment formulation and a dispersal system was pursued. Several microbially-produced 
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VOCs were identified from the scientific literature for their antifungal activities, and tested 
singly and in combinations at various ratios and concentrations. Two in vitro methods were used 
to assess the degree of inhibition caused by gaseous VOCs. The first entailed pipetting aliquots 
of a VOC or formulation on an absorbent disc, then sealing the disc in a Petri dish with freshly-
inoculated spores or mycelial plugs. The second entailed using a sealed glove box to raise the 
headspace concentration by evaporating the VOC or formulation on a hot plate, then sealing a 
glass jar with Petri dishes of freshly-inoculated spores or mycelial plugs from within the glove 
box. This first method was unable to verify the exact gaseous concentration of the exposure, as 
the degree of evaporation was unknown without quantitative analysis. However, the second 
method permitted the exact gaseous concentration to be established at the time of exposure and is 
thought to better represent an exposure typical of a field treatment trial. 
An international PCT patent application was submitted by Georgia State University in 
2014, detailing three effective anti-P. destructans VOC formulations and a VOC dispersal 
system for eliciting microbial control (Gabriel and Cornelison, 2014). 
 
5.4 Wildlife Disease Management 
 
The most effective VOC formulation from the in vitro studies was used in an ex situ 
study with a prototype dispersal device and live bats to determine any negative toxicological 
effects the VOCs may elicit at concentrations likely to be used during treatment. This trial 
yielded no significant toxicological effects and led the way to begin an ex situ infectivity and 
treatment trial with live bats. However, this trial was prematurely canceled due to a lack of 
adequate animal facility management, invalidating all data obtained during the trial. 
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Although several VOC formulations demonstrated significant synergistic inhibitory 
activity, the potential mammalian toxicity and non-GRAS status of several VOCs was a 
significant factor in the decision to pursue experimental treatment with the use of the B-23 
formulation as a treatment agent. This permitted bypassing toxicological evaluations because 
mammalian safety was already established. To this end, the B-23 formulation was tested against 
P. destructans to determine the minimum inhibitory concentration and effective dose. Significant 
inhibition was observed with as little as 24-hour exposure of B-23 at 300 ppmv. Various 
treatment regimens and potential toxicological effects were then explored for this dose. As it 
cannot be assumed that 100% volatilization would occur following aerosolization from the 
treatment device, the evaporative efficiency and environmental fate of B-23 was assessed by 
analyzing air and water samples obtained during field trials at Black Diamond Tunnel, during the 
winter treatment trials of 2016/17. 
 
5.5 Treatment at Black Diamond Tunnel 
 
Although there are not enough data to make any strong conclusions as to whether the three 
treatments during the winter of 2016/17 at Black Diamond Tunnel were effective at reducing bat 
mortality, there were several observations that appear promising. During all three treatments, 
there were no bats observed arousing and flying or leaving the tunnel, indicating the dispersal of 
the treatment formulation, the operation of the L-30, or the use of the capstan winch were not 
significantly disruptive to cause bats to arouse or fly from the tunnel. Furthermore, the second 
bat survey, 1 month after the first treatment, yielded 216 bats. Observing 10 more bats than were 
present preceding the first treatment further strengthens the theory that the bats at this site were 
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not demonstrating an aversion to the B-23 formulation or the methods employed to conduct 
treatment. 
No compounds of the B-23 formulation were detectible from any 1-week post-treatment 
water or air samples. Air samples obtained 1-hour post-treatment yielded detectible compounds 
of the B-23 formulation, with several chromatographic peaks having indicated similar, higher, 
and lower concentrations of specific compounds, when compared to a 300 ppmv gas standard. 
This indicated environmental factors at Black Diamond Tunnel might affect air movement 
dynamics, volatility, and gaseous homogeneity, among other factors. Additionally, only having 
one air sample inlet and placing that inlet near the water level likely contributed to the variability 
of concentrations observed. Future sampling may benefit from including air samples from 
multiple heights within the tunnel, in order to gain a broader understanding of the gaseous 
dynamics in this environment following treatment. 
On February 28, 2017, a bat survey was conducted at Black Diamond Tunnel, yielding 152 
individuals. When the data becomes available, this population count will be compared to surveys 
from other hibernacula in the area to determine if there were any significant differences in 
population dynamics and survivorship that may be attributed to treatment initiatives. Pending no 
significant negative results, treatments will continue be conducted up to the next three years in 
order to strengthen the statistical power of results and conclusions that may be drawn from this 
study. 
 
5.6 Beyond White-Nose Syndrome 
 
This investigation sought to develop safe and efficacious treatment options for bats 
afflicted with WNS, in order to increase fitness and survivorship. However, these treatment 
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methodologies may also aid in managing other wildlife and crop diseases. Other uses being 
investigated include, but are not limited to, treating snake fungal disease (SFD) of snakes 
infected with Ophidiomyces ophiodiicola (Cornelison et al., 2016; Kane et al., 2017), treating 
nosemosis or chalkbrood disease of honey bees (Apis mellifera) infected with Nosema apis or 
Ascosphaera apis, respectively, treating noble rot of crops infected with Botrytis cinerea, 
treating grain contamination by Aspergillus flavus, and treating citrus black spot of citrus (Citrus 
spp.) leaves and fruit infected with Phyllosticta citricarpa. The methods and technologies 
developed during this investigation also have the potential to be used for purposes beyond 
disease management, in many systems where microbial control may be desired. 
Biomimicry has opened the doors to exploring exciting new approaches to solving 
difficult microbial control challenges. By harnessing novel microorganisms and their natural 
antagonistic compounds, technology has allowed us to not only develop a new set of tools and 
techniques for controlling microorganisms but the potential to yield a great number of natural, 
safe, and patentable formulations that enhance both effectiveness and safety of what can be 
found in nature. 
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APPENDICES 
 
APPENDIX A 
 
List of compounds produced by microorganisms that have demonstrated antimicrobial activity. 
 
Citation Volatile Organic Compound Source Organism 
Wang 2013 
Dimethyl sulfide Streptomyces sp. TD-1 
3-caren-10-al Streptomyces sp. TD-2 
Humulen-(v1) Streptomyces sp. TD-3 
Isoledene Streptomyces sp. TD-4 
2-Methylisoborneol Streptomyces sp. TD-1 
Benzene, 1,2,3-trimethyl Streptomyces sp. TD-4 
Yuan 2012 
Toluene Bacillus amyloliquefaciens NJN-6 
Ethylbenzene Bacillus amyloliquefaciens NJN-7 
1,2,4-trimethylbenzene Bacillus amyloliquefaciens NJN-8 
P-xylene Bacillus amyloliquefaciens NJN-9 
Styrene Bacillus amyloliquefaciens NJN-10 
Benzene Bacillus amyloliquefaciens NJN-11 
2-Undecanol Bacillus amyloliquefaciens NJN-12 
2-nonanone Bacillus amyloliquefaciens NJN-13 
2-decanone Bacillus amyloliquefaciens NJN-14 
2-Undecanone Bacillus amyloliquefaciens NJN-15 
Naphthalene Bacillus amyloliquefaciens NJN-16 
Naphthalene, 1-methyl- Bacillus amyloliquefaciens NJN-17 
Naphthalene,2-methyl- Bacillus amyloliquefaciens NJN-18 
Schalchli 2011 
6-Pentyl-α-pyrone Trichoderma viride 
Ethanol Schizophyllum commune (Shi–1) 
Ethanol Schizophyllum commune (Shi–2) 
β-Bisabolol Trametes versicolor  
β-Bisabolol Schizophyllum commune (Shi–1) 
β-Bisabolol Schizophyllum commune (Shi–2) 
Spathulenol Trametes versicolor  
Ethyl 2-methylbutanoate Schizophyllum commune (Shi–1) 
Ethyl 2-methylbutanoate Schizophyllum commune (Shi–2) 
2-Methylbutyl acetate Schizophyllum commune (Shi–1) 
2-Methylbutyl acetate Schizophyllum commune (Shi–2) 
Cadinene Trichoderma viride 
β-Bisabolene Trichoderma viride 
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β-Bisabolene Schizophyllum commune (Shi–1) 
β-Bisabolene Schizophyllum commune (Shi–2) 
Kai 2006 
Dodecanal Stenotrophomonas rhizophila P69 
β-Phenylethanol Stenotrophomonas rhizophila P70 
Dodecanal Staphylococcus epidermidis 
β-Phenylethanol Staphylococcus epidermidis 
Benzylnitrile Serratia plymuthica 
β-Phenylethanol Serratia plymuthica 
Trans-9-hexadecene-1-ol Serratia plymuthica 
β-Phenylethanol Serratia plymuthica 
Dimethyl trisulside Serratia odorifera 
β-Phenylethanol Serratia odorifera 
Undecadiene Pseudomonas trivialis 
Undecene Pseudomonas trivialis 
Benzyloxybenzonitrile Pseudomonas trivialis 
Undecene Pseudomonas fluorescens 
Fernando 2005 
2-ethyl-1-hexanol Pseudomonas spp. 
Benzaldehyde Pseudomonas spp. 
Benzothiazole Pseudomonas spp. 
Decanal Pseudomonas spp. 
N,N-Dimenthyloctylamine Pseudomonas spp. 
Nonanal Pseudomonas spp. 
 
 
APPENDIX B 
 
Phosphate Buffered Saline (PBS) Solution Composition 
 
Component Quantity (per 1 L deionized water) 
NaCl 8 g 
KCl 0.2 g 
Na2PO4 1.44 g 
KH4PO4 0.24 g 
 
Adjust to pH 7.4, then autoclave or filter-sterilize. 
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APPENDIX C 
 
Conidia Harvesting Solution Composition 
Component Quantity (per L of deionized water) 
Tween80 500 ml 
NaCl 4.5 g 
 
Mix until homogeneous, then autoclave. 
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APPENDIX D 
 
Version 1.4.4 source code for the version 1.4 dispersal system controller
 
/*  1 
*  Title:   Automated Dispersal Controller 2 
*  Author:  Kyle T. Gabriel 3 
*  Date:    2013-2016 4 
*  Version: 1.4.4 5 
*  Type:    Arduino Source Code 6 
*  Chip:    ATMEGA328P-PU 7 
*  Board:   version 1.4 8 
*  PHP:     version 1.7 (generates SETTINGS.TXT) 9 
* 10 
*  Compiler:  Arduino IDE 1.0.6 11 
*  Libraries: EEPROMAnything, DS1337, SdFat 12 
* 13 
*  Prior work that was used and modified: 14 
*  SD Card read/write by Alex Shubovich, 15 
*    http://overskill.alexshu.com/?p=107 16 
*  DS1337 RTC Library by Tim, 17 
*    Gipsonhttps://code.google.com/p/mosquino/wiki/DS1337 18 
*  Based on xSmurf's RTC, 19 
*    http://www.arduino.cc/cgi-bin/yabb2/YaBB.pl?num=1191209057/0 20 
*/ 21 
 22 
#include <EEPROM.h>         // Store variables in EEPROM 23 
#include <EEPROMAnything.h> // Store whole arrays in EEPROM 24 
#include <SdFat.h>          // Read/Write SD Card 25 
#include <DS1337.h>         // Real Time Clock 26 
#include <Wire.h>           // Real Time Clock 27 
#include <avr/power.h>      // Real Time Clock 28 
#include <avr/sleep.h>      // Real Time Clock 29 
#include <math.h>           // Calculations for thermistor 30 
 31 
// Enable (1) or disable (0) debug mode (print status to serial) 32 
#define DEBUG 0 33 
 34 
#define int2Pin 2       // Real Time Clock interrupt (pin 2, INT0) 35 
#define ledPin 4        // LED for indicating status 36 
#define mosfetPin 6     // MOSFET to switch power to dispersal device 37 
#define vflowPin 9      // N- and P-MOSFETs, switch battery to voltage divider 38 
#define vreadPin 14     // Read 12v battery voltage through voltage divider 39 
#define tempPin 17      // Read voltage of 10k thermistor 40 
#define SDcardPin 15    // card select of SD card reader (D3 of breakout board) 41 
#define SDcardInsPin 16 // SD-card (CD) (not inserted = 3.3v, inserted = gnd) 42 
 43 
// Filenames written/read from the SD card 44 
#define LOCKFILE "LOCK.TXT" 45 
#define SETTINGS "SETTINGS.TXT" 46 
#define LOG "LOG.TXT" 47 
 48 
// SD card connections 49 
// D3   -  cardSelect (pin 15, ADC1) 50 
// CMD  -  MOSI 51 
// CD   -  cardDetect (pin 16, ADC2) 52 
// CLK  -  SCK 53 
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// D0   -  MISO 54 
// VDD  -  Power: Positive 3.3-volt 55 
// GND  -  Power: Ground 56 
SdFat sd; 57 
SdFile myFile; 58 
 59 
// Real time clock (RTC) for timekeeping and timers 60 
DS1337 RTC = DS1337(); 61 
long timers[3];        // Stores how many seconds until each timer ends 62 
long startTime;        // The epoch time when the device turns on 63 
long timeTotal;        // The epoch time every time the device wakes 64 
long offTimer;         // The epoch time when the device turns off 65 
long logTimer;         // Determines batteryCheck() run interval 66 
long minTimer;         // Stores lowest timer duration time remaining 67 
 68 
int ArrayCount = 0; 69 
int DurArrayCount = 0; 70 
int FirstCusRun = 1; 71 
 72 
// Variables read from SETTINGS.TXT on SD card 73 
char fileID[14];         // Unique ID of generated configuration file 74 
long TotalRun = -1;      // All operation will cease after this duration 75 
long Delay = -1;         // Delay after powering on until the first dispersal begins 76 
int DurOn = 0;           // Duration to distribute compound 77 
long DurOff = 0;         // Seconds between distributions 78 
long DurLog = 360;       // Time between appending log 79 
long ArrayDurOff[5];     // Store Off Durations for custom program 80 
int ArrayDurOn[5];       // Store On Durations for custom program (seconds=x/10) 81 
int Arrayppmv[5];        // Store ppmv for custom program 82 
int MolW = -1;           // Molecular weight of compound dispersed (g/mol) (actual=x/10) 83 
int CpndSlp = -1;        // Compound dispersal rate (g/sec) (actual=x/10000) 84 
int Atm = -1;            // Atmospheric pressure (atm) (actual=x/10) 85 
int Vol = -1;            // Volume to treat (m^3) (actual=x/10) 86 
int ppmv = -1;           // Parts per million (volume/volume) 87 
int Cus_Num = 0;         // Store the custom number of on/off/ppmv 88 
boolean Custom = false;  // Basic or custom program? 89 
boolean Cus_Rep = false; // Repeat after the last Off Duration? 90 
boolean IntTemp = false; // Use internal temperature sensor? 91 
int lowVoltage = 0;      // Minimum voltage to trigger low voltage warning (actual=x/10) 92 
 93 
struct config_t {        // Variables to store in EEPROM 94 
 boolean BatLow;      // Battery voltage low 95 
} progvar; 96 
 97 
void setup() { 98 
 Serial.begin(9600); 99 
 delay(10); 100 
 101 
 pinMode(ledPin, OUTPUT); 102 
    pinMode(mosfetPin, OUTPUT); 103 
 104 
 space(); dash(); dot(); dot(); dash(); // Flash LED: Setup begins 105 
 106 
 pinMode(vflowPin, OUTPUT);    // Opens 12-volt flow to voltage divider 107 
    pinMode(SDcardInsPin, INPUT); // SD card insert detection 108 
 pinMode(SDcardPin, OUTPUT);   // SD card 109 
 pinMode(int2Pin, INPUT);      // Interrupt pin for DS1337 alarm 110 
 digitalWrite(int2Pin, HIGH);  // Pull-up resistor enabled for RTC interrupt 111 
 112 
    if (digitalRead(SDcardInsPin) == HIGH) { // No SD card inserted 113 
  while(1) { 114 
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            space(); dash(); dash(); dash(); dot(); 115 
            delay(5000); 116 
        } 117 
 } 118 
 119 
 if (!sd.begin(SDcardInsPin, SPI_HALF_SPEED)) { // SD card init failed 120 
  while(1) { 121 
            space(); dash(); dash(); dot(); dot(); 122 
            delay(5000); 123 
        } 124 
 } else readSDSettings();  // Read variables from the SD card 125 
 126 
    // If the LOCKFILE is present, the program has previously ended. 127 
    // The user must delete LOCKFILE from the SD card to permit the 128 
    // program to run again. 129 
    if (myFile.open(LOCKFILE, O_READ)) { 130 
        while(1) { 131 
            space(); dash(); dot(); dash(); dot(); 132 
            delay(2000); 133 
        } 134 
    } 135 
 136 
    EEPROM_readAnything(0, progvar); 137 
    progvar.BatLow = false; 138 
    EEPROM_writeAnything(0, progvar); 139 
 140 
    // Initialize Real Time Clock (RTC) 141 
 RTC.start(); 142 
 143 
    // If RTC not set, set time to epoch 144 
 if (!RTC.time_is_set()) { 145 
  Serial.println(F("Clock unset, set to 1/1/2000 epoch (946684800 seconds).")); 146 
  RTC.setSeconds(0); 147 
  RTC.setMinutes(0); 148 
  RTC.setHours(0); 149 
  RTC.setDays(1); 150 
  RTC.setMonths(1); 151 
  RTC.setYears(2000); 152 
  RTC.writeTime(); 153 
 } 154 
 155 
    // Read and record program start time from RTC 156 
 RTC.readTime(); 157 
 startTime = RTC.date_to_epoch_seconds(); 158 
 159 
    // Initial battery voltage check 160 
 if ((float)batteryVoltage() / 100.0 < lowVoltage / 10.0) { 161 
     writeErrorLog(4); 162 
  while(1) { 163 
            dash(); dot(); dot(); dash(); 164 
            delay(5000); 165 
        } 166 
 } 167 
 168 
 updateOnDur();  // Initial duration update 169 
 writeLogInit(); // Initial log amendment 170 
 171 
    // Indicate pre-run setup executed without error 172 
 dot(); dash(); dash(); dot(); 173 
 174 
    // Sleep for pre-run delay 175 
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 RTC.snooze(Delay); 176 
 177 
    // Record time and set log timer, after delay 178 
 RTC.readTime(); 179 
 timeTotal = RTC.date_to_epoch_seconds(); 180 
 logTimer = timeTotal - DurLog; 181 
} 182 
 183 
void loop() { 184 
    // Set current time to compare to timers 185 
    RTC.readTime(); 186 
    timeTotal = RTC.date_to_epoch_seconds(); 187 
 188 
    // Permanently end program if TotalRun has elapsed 189 
    if ((Cus_Rep || !Custom) && timeTotal - startTime >= TotalRun) { 190 
        end_Program(); 191 
    } 192 
 193 
    // Check temperature/voltage and update the On Duration 194 
    if (timeTotal - logTimer >= DurLog) { 195 
        readTemperature(); 196 
        updateOnDur(); 197 
        writeLogUpdate(); 198 
        if ((float)batteryVoltage() / 100.0 < lowVoltage / 10.0) { 199 
            if (!progvar.BatLow) {  200 
                progvar.BatLow = true; 201 
                EEPROM_writeAnything(0, progvar); 202 
                writeErrorLog(4); 203 
            } 204 
        } else if (progvar.BatLow) { 205 
            progvar.BatLow = false; 206 
            EEPROM_writeAnything(0, progvar); 207 
        } 208 
        logTimer = timeTotal; // Reset timer 209 
    } 210 
 211 
    // Turn dispersal device on for appropriate duration of time 212 
    power_On(); 213 
 214 
    // Calculate the lowest remaining off time of all timers 215 
    calc_minTimer(); 216 
 217 
    // Print debug information to serial 218 
    if (DEBUG) debug_Log(); 219 
 220 
    // Sleep until timer has expired 221 
    if (minTimer > 0) RTC.snooze(minTimer); 222 
} 223 
 224 
// Send status messages to serial 225 
void debug_Log() { 226 
    Serial.println(); 227 
    Serial.print(millis()); 228 
    Serial.print(F(" ")); 229 
    Serial.print(timeTotal - startTime); 230 
    Serial.print(F(" ")); 231 
    Serial.print(readTemperature()); 232 
    Serial.print(F(" ")); 233 
    Serial.print(minTimer); 234 
    //Serial.print(" "); 235 
    //for (byte mask = 0x80; mask; mask >>= 1) { // Print the 8 bits of a byte 236 
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    // if (mask & progvar.errorSav) Serial.print('1'); 237 
    // else Serial.print('0'); 238 
    //} 239 
    Serial.println(); 240 
    Serial.flush(); 241 
} 242 
 243 
// Indicate the program has ended and create LOCKFILE to prevent restarting 244 
void end_Program() { 245 
    writeLogEnd(); 246 
         247 
    myFile.open(LOCKFILE, O_RDWR | O_CREAT | O_AT_END); 248 
    myFile.println(F("This file was created by a finished dispersal regimen.")); 249 
    myFile.println(F("Delete this file to permit a new regimen to run.")); 250 
    myFile.close(); 251 
 252 
    while(1) { 253 
        digitalWrite(ledPin, HIGH); 254 
        delay(10); 255 
        digitalWrite(ledPin, LOW); 256 
        RTC.snooze(10); // Sleep 10 seconds 257 
    } 258 
} 259 
 260 
// Calculate new on duration (milliseconds) based on measured temperature and user input 261 
void updateOnDur() { 262 
 if (IntTemp) { 263 
  float Conc_g_per_V; 264 
  if (Custom) { 265 
   for (int i = 0; i < Cus_Num; i++) { 266 
    Conc_g_per_V = (((12.187 * Arrayppmv[i] * ((float)MolW / 10.0)) / 267 
(273.15 + readTemperature())) * ((float)Atm / 10.0)) * ((float)Vol / 10.0); 268 
    ArrayDurOn[i] = Conc_g_per_V / CpndSlp * 100; 269 
   } 270 
  } else { 271 
   Conc_g_per_V = ((12.187 * ppmv * ((float)MolW / 10.0)) / (273.15 + 272 
readTemperature())) * ((float)Atm / 10.0) * ((float)Vol / 10.0); 273 
   DurOn = Conc_g_per_V / CpndSlp * 100; 274 
  } 275 
 } 276 
} 277 
 278 
// Turn the distribution device on for a calculated or specified duration of time 279 
void power_On() { 280 
    if (FirstCusRun) { 281 
        writeLogOn(); 282 
        digitalWrite(ledPin, HIGH); 283 
        digitalWrite(mosfetPin, HIGH); 284 
        if (Custom) { 285 
            delay((long)ArrayDurOn[DurArrayCount] * 100); 286 
            timeTotal = timeTotal + (ArrayDurOn[DurArrayCount] / 10); 287 
        } else {  288 
            delay(DurOn * 100); 289 
            timeTotal = timeTotal + (DurOn / 10); 290 
        } 291 
        digitalWrite(ledPin, LOW); 292 
        digitalWrite(mosfetPin, LOW); 293 
        offTimer = timeTotal; 294 
        FirstCusRun = 0; 295 
    } else if (!Custom && timeTotal - offTimer >= DurOff) { 296 
        writeLogOn(); 297 
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        digitalWrite(ledPin, HIGH); 298 
        digitalWrite(mosfetPin, HIGH); 299 
        delay((long)DurOn * 100); 300 
        digitalWrite(ledPin, LOW); 301 
        digitalWrite(mosfetPin, LOW); 302 
        timeTotal = timeTotal + (DurOn / 10); 303 
        offTimer = timeTotal; 304 
    } else if (Custom && timeTotal - offTimer >= ArrayDurOff[DurArrayCount]) { 305 
        if (Cus_Rep && DurArrayCount >= Cus_Num - 1) { 306 
            DurArrayCount = 0; 307 
        } else DurArrayCount++; 308 
        writeLogOn(); 309 
        digitalWrite(ledPin, HIGH); 310 
        digitalWrite(mosfetPin, HIGH); 311 
        delay((long)ArrayDurOn[DurArrayCount] * 100); 312 
        digitalWrite(ledPin, LOW); 313 
        digitalWrite(mosfetPin, LOW); 314 
        timeTotal = timeTotal + (ArrayDurOn[DurArrayCount] / 10); 315 
        offTimer = timeTotal; 316 
        if (!Cus_Rep && DurArrayCount >= Cus_Num - 1) end_Program(); 317 
    } 318 
} 319 
 320 
// Determine the lowest time remaining from all timers 321 
// This is how long the processor will sleep for 322 
long calc_minTimer() { 323 
    if (!Cus_Rep) timers[0] = 31536000; 324 
    else { 325 
        if (TotalRun - (timeTotal - startTime) <= 0) timers[0] = 0; 326 
        else timers[0] = TotalRun - (timeTotal - startTime); // total time remaining 327 
    } 328 
    if (Custom) timers[1] = ArrayDurOff[DurArrayCount] - (timeTotal - offTimer); 329 
    else timers[1] = DurOff - (timeTotal - offTimer); // remaining time off 330 
    timers[2] = DurLog - (timeTotal - logTimer); // remaining time until log 331 
 332 
    // Determine which timer has the lowest time remaining 333 
    minTimer = timers[0]; 334 
    for (int i = 1; i < 3; i++) { 335 
        if (minTimer > timers[i] && timers[i] > 0) minTimer = timers[i]; 336 
    } 337 
} 338 
 339 
// Write an initial log entry for the current dispersal regimen 340 
void writeLogInit() { 341 
 myFile.open(LOG, O_RDWR | O_CREAT | O_AT_END); 342 
 myFile.println(); 343 
 myFile.print(F("Seconds,FileID,Delay")); 344 
 if (Cus_Rep || !Custom) myFile.print(F(",Total")); 345 
 if (IntTemp) myFile.print(F(",Temp,MW,Atm,Vol,Rate")); 346 
 if (Custom) { 347 
  for (int i = 0; i < Cus_Num; i++) { 348 
   if (IntTemp) { 349 
    myFile.print(F(",ppm")); 350 
    myFile.print(i); 351 
   } 352 
   myFile.print(F(",On")); 353 
   myFile.print(i); 354 
   if (i == Cus_Num - 1 && !Cus_Rep) { 355 
   } else { 356 
    myFile.print(F(",Off")); 357 
    myFile.print(i); 358 
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   } 359 
  } 360 
 } else { 361 
  if (IntTemp) myFile.print(F(",ppm")); 362 
  myFile.print(F(",On,Off")); 363 
 } 364 
  365 
 myFile.println(); 366 
 myFile.print(F("0,")); 367 
 myFile.print(fileID); 368 
    myFile.print(Delay); 369 
 if (Cus_Rep || !Custom) { 370 
  myFile.print(F(",")); 371 
  myFile.print(TotalRun); 372 
 } 373 
 if (IntTemp) { 374 
  myFile.print(F(",")); 375 
  myFile.print(readTemperature()); 376 
  myFile.print(F(",")); 377 
  myFile.print((float)MolW/ 10.0, 1); 378 
  myFile.print(F(",")); 379 
  myFile.print((float)Atm / 10.0, 1); 380 
  myFile.print(F(",")); 381 
  myFile.print((float)Vol / 10.0, 1); 382 
  myFile.print(F(",")); 383 
  myFile.print((float)CpndSlp / 10000.0, 4); 384 
 } 385 
 if (Custom) { 386 
  for (int i = 0; i < Cus_Num; i++) { 387 
   if (IntTemp) { 388 
    myFile.print(F(",")); 389 
    myFile.print(Arrayppmv[i]); 390 
   } 391 
   myFile.print(F(",")); 392 
   myFile.print((float)ArrayDurOn[i] / 10.0, 1); 393 
   if (i == Cus_Num - 1 && !Cus_Rep) { 394 
   } else { 395 
    myFile.print(F(",")); 396 
    myFile.print(ArrayDurOff[i]); 397 
   } 398 
  } 399 
 } else { 400 
  if (IntTemp) { 401 
   myFile.print(F(",")); 402 
   myFile.print(ppmv); 403 
  } 404 
  myFile.print(F(",")); 405 
  myFile.print((float)DurOn / 10.0, 1); 406 
  myFile.print(F(",")); 407 
  myFile.print(DurOff); 408 
 } 409 
 myFile.println(); 410 
 myFile.print(F("Seconds,Type,On,Temp,Volts")); 411 
 if (IntTemp) { 412 
  if (Custom) { 413 
   for (int i = 0; i < Cus_Num; i++) { 414 
    myFile.print(F(",On(")); 415 
    myFile.print(i); 416 
    myFile.print(F(")")); 417 
   } 418 
  } else myFile.print(F(",On")); 419 
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 } 420 
 myFile.println(); 421 
 myFile.close(); 422 
} 423 
 424 
// Write the duration to the log file when the distribution device turns on 425 
void writeLogOn() { 426 
 myFile.open(LOG, O_RDWR | O_CREAT | O_AT_END);  427 
 myFile.print(timeTotal - startTime); 428 
 myFile.print(F(",On")); 429 
 if (Custom) { 430 
  myFile.print(DurArrayCount); 431 
  myFile.print(F(",")); 432 
  myFile.print((float)ArrayDurOn[DurArrayCount] / 10.0, 1); 433 
 } else { 434 
  myFile.print(F(",")); 435 
  myFile.print((float)DurOn / 10.0, 1); 436 
 } 437 
 myFile.println(); 438 
 myFile.close(); 439 
} 440 
 441 
// Write periodic updates of battery voltage and temperature to the log 442 
void writeLogUpdate() { 443 
 myFile.open(LOG, O_RDWR | O_CREAT | O_AT_END);  444 
 myFile.print(timeTotal - startTime); 445 
 myFile.print(F(",UPDATE,,")); 446 
 myFile.print(readTemperature()); 447 
 myFile.print(F(",")); 448 
 myFile.print((float)batteryVoltage() / 100.0); 449 
 if (IntTemp) { 450 
  if (Custom) { 451 
   for (int i = 0; i < Cus_Num; i++) { 452 
    myFile.print(F(",")); 453 
    myFile.print((float)ArrayDurOn[i] / 10.0,1); 454 
    } 455 
  } else { 456 
   myFile.print(F(",")); 457 
   myFile.print((float)DurOn / 10.0,1); 458 
  } 459 
 } 460 
 myFile.println(); 461 
 myFile.close(); 462 
} 463 
 464 
// Write the last log line of the dispersal regimen 465 
void writeLogEnd() { 466 
 myFile.open(LOG, O_RDWR | O_CREAT | O_AT_END);  467 
 myFile.print(timeTotal - startTime); // Seconds since the device began running 468 
 myFile.print(F(",The device has reached the scheduled end.")); 469 
 myFile.println(); 470 
 myFile.close(); 471 
} 472 
 473 
// Write error description to the log 474 
void writeErrorLog(int i) { 475 
 myFile.open(LOG, O_RDWR | O_CREAT | O_AT_END);  476 
 myFile.print(timeTotal - startTime); 477 
 myFile.print(F(",ERROR,")); 478 
        switch (i) { 479 
            case 1: 480 
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                myFile.print(F("")); 481 
                break; 482 
            case 2: 483 
                myFile.print(F("")); 484 
                break; 485 
            case 3: 486 
                myFile.print(F("SETTINGS.TXT improperly configured.")); 487 
                break; 488 
            case 4: 489 
                myFile.print(F("Battery charge too low.")); 490 
                break; 491 
            default: 492 
                myFile.print(F("UNKNOWN ERROR.")); 493 
                break; 494 
        } 495 
 myFile.println(); 496 
 myFile.close(); 497 
} 498 
 499 
// Reads SETTINGS.TXT for operational parameters 500 
void readSDSettings() { 501 
 char character; 502 
 String settingName; 503 
 String settingValue; 504 
 myFile.open(SETTINGS, O_READ); 505 
 while ((character = myFile.read()) >= 0) { 506 
  while(character != '='){ 507 
   settingName = settingName + character; 508 
   character = myFile.read(); 509 
  } 510 
  character = myFile.read(); 511 
  while(character != '\n'){ 512 
   settingValue = settingValue + character; 513 
   character = myFile.read(); 514 
   if (character == '\n' || character == ','){ 515 
    //Debuuging Printing 516 
    Serial.print(settingName); 517 
    Serial.print(F("=")); 518 
    Serial.println(settingValue); 519 
    // Apply the value to the parameter 520 
    applySetting(settingName,settingValue); 521 
    // Reset Strings 522 
    settingValue = ""; 523 
    if (character == ',') { 524 
     ArrayCount++; 525 
     character = myFile.read(); 526 
    } else settingName = ""; 527 
   } 528 
  } 529 
  ArrayCount = 0; 530 
 } 531 
 // close the file: 532 
 myFile.close(); 533 
} 534 
 535 
// Apply the value to the parameter by searching for the parameter name 536 
// Using settingValue.toInt(); for Integers 537 
// toFloat(settingValue); for Float 538 
// toBoolean(settingValue); for Boolean 539 
void applySetting(String settingName, String settingValue) { 540 
 if (settingName == "FILEID") settingValue.toCharArray(fileID, 14); 541 
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 if (settingName == "TotalRun") TotalRun = settingValue.toInt(); 542 
 if (settingName == "Delay") Delay = settingValue.toInt(); 543 
 if (settingName == "IntTemp") IntTemp = toBoolean(settingValue); 544 
 if (settingName == "Custom") Custom = toBoolean(settingValue); 545 
 if (settingName == "Cus_Rep") Cus_Rep = toBoolean(settingValue); 546 
 if (settingName == "Cus_Num") Cus_Num = settingValue.toInt(); 547 
 if (settingName == "DurOn") DurOn = settingValue.toInt(); 548 
 if (settingName == "DurOff") DurOff = settingValue.toInt(); 549 
 if (settingName == "DurLog") DurLog = settingValue.toInt(); 550 
 if (settingName == "MolW") MolW = settingValue.toInt(); 551 
 if (settingName == "CpndSlp") CpndSlp = settingValue.toInt(); 552 
 if (settingName == "Atm") Atm = settingValue.toInt(); 553 
 if (settingName == "Vol") Vol = settingValue.toInt(); 554 
 if (settingName == "ppmv") ppmv = settingValue.toInt(); 555 
 if (settingName == "ZDurOn") ArrayDurOn[ArrayCount] = settingValue.toInt(); 556 
 if (settingName == "ZDurOff") ArrayDurOff[ArrayCount] = settingValue.toInt(); 557 
 if (settingName == "ZOnppmv") Arrayppmv[ArrayCount] = settingValue.toInt(); 558 
    if (settingName == "lowVoltage") lowVoltage = settingValue.toInt(); 559 
} 560 
 561 
// Convert string to float 562 
float toFloat(String settingValue) { 563 
 char floatbuf[settingValue.length()]; 564 
 settingValue.toCharArray(floatbuf, sizeof(floatbuf)); 565 
 float f = atof(floatbuf); 566 
 return f; 567 
} 568 
 569 
// Convert string to integer and then to boolean (1=true, 0=false) 570 
boolean toBoolean(String settingValue) { 571 
 if(settingValue.toInt()==1) return true; 572 
 else return false; 573 
} 574 
 575 
// Read temperature from thermistor 576 
float readTemperature() { 577 
    int RawADC = 0; 578 
    for (int i = 0; i < 3; i++) { 579 
        RawADC = RawADC + analogRead(tempPin); 580 
    } 581 
    RawADC = RawADC / 3; 582 
    // a1, b1, c1, d1 constants for calculating temperature with NTC thermistor 583 
    float abcd[] = { 3.354016E-03, 2.569850E-04, 2.620131E-06, 6.383091E-08 }; 584 
    // Rref = the reference temp of 25degC; in c, log is natural log 585 
    // Rfixed = 9999.5 ohms, fixed resistor (lower half of voltage divider) 586 
 float lnR = log (((9999.5/(RawADC*3.3/1023.0))*3.3 - 9999.5)/10000.0); 587 
 float invT = abcd[0] + abcd[1]*lnR + abcd[2]*lnR*lnR + abcd[3]*lnR*lnR*lnR; 588 
 float Temp_C = (1/invT) - 273.15; 589 
    return Temp_C; 590 
} 591 
 592 
// Read battery voltage 593 
int batteryVoltage() { 594 
 digitalWrite(vflowPin, HIGH); 595 
 delay(100); 596 
 int rawValue = analogRead(vreadPin); 597 
 digitalWrite(vflowPin, LOW); 598 
 int batteryVoltage = (rawValue * 12.64 / 1023.0) * 100; 599 
    return batteryVoltage; 600 
} 601 
 602 
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// Alternate method to read battery voltage 603 
uint16_t readBat(uint8_t ch) { // Circuit: GND---[R10k]---A0---[R5k]---12V 604 
 ADMUX = (1<<REFS0);                         // For Aref=AVcc; 605 
 ADCSRA = (1<<ADEN) | (1<<ADPS2) | (1<<ADPS1) | (1<<ADPS0); //Rrescalar 606 
 ch = ch & 0b00000111; //Select ADC Channel ch must be 0-7 607 
 ADMUX |= ch; 608 
 ADCSRA |= (1<<ADSC); //Start Single conversion 609 
 while(ADCSRA & (1<<ADSC)); //Wait for conversion to complete 610 
 return(ADC); 611 
} 612 
 613 
// LED communication modeled after Morse code: dot, dash, space 614 
void dot() { 615 
 digitalWrite(ledPin, HIGH); 616 
 delay(300); 617 
 digitalWrite(ledPin, LOW); 618 
 delay(300); 619 
} 620 
void dash() { 621 
 digitalWrite(ledPin, HIGH); 622 
 delay(900); 623 
 digitalWrite(ledPin, LOW); 624 
 delay(300); 625 
} 626 
void space() { 627 
 delay(600); 628 
} 629 
